HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
101091.0,273922,2104-12-14 15:04:00,Physician ,Physician Attending Progress Note,"Chief Complaint: Respiratory distress
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   Pt. known to MICU service from 2 prior recent MICU transfers during
   present hospitalization.  Most recently transferred back to medical
   [**Hospital1 **] [**2104-12-12**].
   Currently returns for marked hypoxemia, malaise, significant cough
   (non-productive) and persistent respiratory distress.  Awakened this AM
   with malaise, fatigue but no chest pain.  ABG= 7.46/38/65.  Hypoxemia
   requred increased FIO2 by face mask with good effect.  Scheduled for
   repeat CT angio and transfer back to MICU service for additional
   evaluation and management.
   Upon arrival to MICU, states to feel improved.  Good SaO2 on NC.
   Noted to have new skin rash -- erythematous macular-papular rash over
   trunk/back.  Non-prurutic.
   Denies increased cough, sputum, hemoptysis, chest pain, pleurisy.
   Denies abd pain, back pain.
   History obtained from [**Hospital 31**] Medical records
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fatigue, No(t) Fever, No(t) Weight loss
   Eyes: No(t)  Blurry vision, No(t) Conjunctival edema
   Ear, Nose, Throat: No(t) Dry mouth, No(t) Epistaxis, No(t) OG / NG tube
   Cardiovascular: No(t) Chest pain, No(t) Palpitations, No(t) Edema,
   No(t) Tachycardia, No(t) Orthopnea
   Nutritional Support: NPO, No(t) Tube feeds, No(t) Parenteral nutrition
   Respiratory: No(t) Cough, No(t) Dyspnea, No(t) Tachypnea, No(t) Wheeze
   Gastrointestinal: No(t) Abdominal pain, No(t) Nausea, No(t) Emesis,
   No(t) Diarrhea, No(t) Constipation
   Genitourinary: No(t) Dysuria, Foley, No(t) Dialysis
   Musculoskeletal: No(t) Joint pain, No(t) Myalgias
   Integumentary (skin): No(t) Jaundice, No(t) Rash
   Endocrine: Hyperglycemia, No(t) History of thyroid disease
   Heme / Lymph: No(t) Lymphadenopathy, No(t) Anemia, No(t) Coagulopathy
   Neurologic: No(t) Numbness / tingling, No(t) Headache, No(t) Seizure
   Psychiatric / Sleep: No(t) Agitated, No(t) Suicidal, No(t) Delirious,
   No(t) Daytime somnolence, Appears depressed
   Allergy / Immunology: Immunocompromised, No(t) Influenza vaccine
   Signs or concerns for abuse : No
   Pain: No pain / appears comfortable
   Flowsheet Data as of  [**2104-12-14**] 03:03 PM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.4
C (97.6
   Tcurrent: 36.4
C (97.6
   HR: 104 (97 - 106) bpm
   BP: 110/66(77) {110/66(77) - 129/78(90)} mmHg
   RR: 14 (14 - 25) insp/min
   SpO2: 93%
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
             35 mL
   PO:
             TF:
   IVF:
   35 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                      0 mL
   Urine:
   NG:
   Stool:
   Drains:
   Balance:
                                                                      0 mL
                                                                     35 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 93%
   ABG: ////
   Physical Examination
   General Appearance: Well nourished, No(t) No acute distress, No(t)
   Overweight / Obese, No(t) Thin, No(t) Anxious, No(t) Diaphoretic,
   Chronically ill
   Eyes / Conjunctiva: PERRL, No(t) Pupils dilated, No(t) Conjunctiva
   pale, No(t) Sclera edema
   Head, Ears, Nose, Throat: Normocephalic, No(t) Poor dentition, No(t)
   Endotracheal tube, No(t) NG tube, No(t) OG tube
   Lymphatic: Cervical WNL, No(t) Supraclavicular WNL, No(t) Cervical
   adenopathy
   Cardiovascular: (PMI Normal, No(t) Hyperdynamic), (S1: Normal, No(t)
   Absent), (S2: Normal, No(t) Distant, No(t) Loud, No(t) Widely split ,
   No(t) Fixed), No(t) S3, No(t) S4, No(t) Rub, (Murmur: Systolic, No(t)
   Diastolic)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric, No(t) Paradoxical),
   (Percussion: Resonant : , No(t) Hyperresonant: , No(t) Dullness : ),
   (Breath Sounds: No(t) Clear : , No(t) Crackles : , No(t) Bronchial: ,
   No(t) Wheezes : , No(t) Diminished: , No(t) Absent : , Rhonchorous:
   scattered)
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended,
   No(t) Tender: , No(t) Obese
   Extremities: Right: Trace, Left: Trace, No(t) Cyanosis, No(t) Clubbing
   Musculoskeletal: Muscle wasting, Unable to stand
   Skin:  Warm, Rash: macular-papular erythematous rash over trunk, No(t)
   Jaundice
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, No(t) Oriented (to): , Movement: Purposeful, No(t) Sedated,
   No(t) Paralyzed, Tone: Normal
   Labs / Radiology
   11.9 g/dL
   296 K/uL
   90 mg/dL
   0.9 mg/dL
   26 mEq/L
   4.4 mEq/L
   12 mg/dL
   107 mEq/L
   141 mEq/L
   34.5 %
   11.4 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   Plt
   [**Telephone/Fax (3) 3174**]03
   296
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   Glucose
   90
   105
   104
   100
   90
   Other labs: Differential-Neuts:81.0 %, Band:0.0 %, Lymph:5.0 %,
   Mono:9.0 %, Eos:4.0 %, Ca++:8.7 mg/dL, Mg++:2.3 mg/dL, PO4:2.7 mg/dL
   Imaging: CT angio with no evidence for PE.  However, interval
   development of multiple densities, LLL >> RLL and mid lung zones.
   Assessment and Plan
   HYPOXEMIA -- attributed to new pneumonia on background of RSV
   infection.   No evidence for pulmonary embolism by today's CT scan.
   Evidence for new pulmonary infiltrates on right and left upper lobes
   --> possibly representing new infection or process (ex. PcP or other
   fungal infection), progression of underlying infection, complication of
   medications (ex. related to rash, related to antibody administration).
   Plan continue supplimental oxygen, monitor RR, maintain SaO2 > 90%,
   continue empirical antimicrobials.  Provide beta-agonist.  Check on
   next scheduled PcP prophylaxis Would check LE NIVS to assess for DVT.
   Check beta-galactomannan.  Consider bronchoscopy, although would
   require intubation to perform procedure safely.  Low threshold for
   intubation in event of clinical decline.
   PNEUMONIA (HAP) -- clinical variability on current regimen.  Doubt OI.
   Consider bronchoscopic investigation.  Continue current level of care.
   Interval development of multiple pulmonary infiltates  may represent
   aspiration or atuypical pneuonia, but may also represent process such
   as right-sided endovascular infeciton (ex. endocarditis, line-related
   infection).  Check blood cultures, consider repeat echo.
   RSV infection -- s/p antibody treatment.
   Cough -- attributed to RSV and HAP.  Improving.
   RASH -- new development;  appears drug-related, and currently receiving
   several potential offenders, including contrast dye (CT angio).
   CML s/p SCT c/b GVHD
 continue current level of care.
   GI GVHD -- continue oral swish and spit.
   NUTRITIONAL SUPPORT
 encourage PO with suppliments.
   DEPRESSED MOOD -- consider pharmacological  intervention.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   20 Gauge - [**2104-12-14**] 10:59 AM
   Prophylaxis:
   DVT: Boots(Systemic anticoagulation: None)
   Stress ulcer: H2 blocker
   VAP: HOB elevation
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :ICU
   Total time spent: 45 minutes
   Patient is critically ill
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Respiratory distress
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   Pt. known to MICU service from 2 prior recent MICU transfers during
   present hospitalization.  Most recently transferred back to medical
   [**Hospital1 **] [**2104-12-12**].
   Currently returns for marked hypoxemia, malaise, significant cough
   (non-productive) and persistent respiratory distress.  Awakened this AM
   with malaise, fatigue but no chest pain.  ABG= 7.46/38/65.  Hypoxemia
   requred increased FIO2 by face mask with good effect.  Scheduled for
   repeat CT angio and transfer back to MICU service for additional
   evaluation and management.
   Upon arrival to MICU, states to feel improved.  Good SaO2 on NC.
   Noted to have new skin rash -- erythematous macular-papular rash over
   trunk/back.  Non-prurutic.
   Denies increased cough, sputum, hemoptysis, chest pain, pleurisy.
   Denies abd pain, back pain.
   History obtained from [**Hospital 31**] Medical records
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fatigue, No(t) Fever, No(t) Weight loss
   Eyes: No(t)  Blurry vision, No(t) Conjunctival edema
   Ear, Nose, Throat: No(t) Dry mouth, No(t) Epistaxis, No(t) OG / NG tube
   Cardiovascular: No(t) Chest pain, No(t) Palpitations, No(t) Edema,
   No(t) Tachycardia, No(t) Orthopnea
   Nutritional Support: NPO, No(t) Tube feeds, No(t) Parenteral nutrition
   Respiratory: No(t) Cough, No(t) Dyspnea, No(t) Tachypnea, No(t) Wheeze
   Gastrointestinal: No(t) Abdominal pain, No(t) Nausea, No(t) Emesis,
   No(t) Diarrhea, No(t) Constipation
   Genitourinary: No(t) Dysuria, Foley, No(t) Dialysis
   Musculoskeletal: No(t) Joint pain, No(t) Myalgias
   Integumentary (skin): No(t) Jaundice, No(t) Rash
   Endocrine: Hyperglycemia, No(t) History of thyroid disease
   Heme / Lymph: No(t) Lymphadenopathy, No(t) Anemia, No(t) Coagulopathy
   Neurologic: No(t) Numbness / tingling, No(t) Headache, No(t) Seizure
   Psychiatric / Sleep: No(t) Agitated, No(t) Suicidal, No(t) Delirious,
   No(t) Daytime somnolence, Appears depressed
   Allergy / Immunology: Immunocompromised, No(t) Influenza vaccine
   Signs or concerns for abuse : No
   Pain: No pain / appears comfortable
   Flowsheet Data as of  [**2104-12-14**] 03:03 PM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.4
C (97.6
   Tcurrent: 36.4
C (97.6
   HR: 104 (97 - 106) bpm
   BP: 110/66(77) {110/66(77) - 129/78(90)} mmHg
   RR: 14 (14 - 25) insp/min
   SpO2: 93%
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
             35 mL
   PO:
             TF:
   IVF:
   35 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                      0 mL
   Urine:
   NG:
   Stool:
   Drains:
   Balance:
                                                                      0 mL
                                                                     35 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 93%
   ABG: ////
   Physical Examination
   General Appearance: Well nourished, No(t) No acute distress, No(t)
   Overweight / Obese, No(t) Thin, No(t) Anxious, No(t) Diaphoretic,
   Chronically ill
   Eyes / Conjunctiva: PERRL, No(t) Pupils dilated, No(t) Conjunctiva
   pale, No(t) Sclera edema
   Head, Ears, Nose, Throat: Normocephalic, No(t) Poor dentition, No(t)
   Endotracheal tube, No(t) NG tube, No(t) OG tube
   Lymphatic: Cervical WNL, No(t) Supraclavicular WNL, No(t) Cervical
   adenopathy
   Cardiovascular: (PMI Normal, No(t) Hyperdynamic), (S1: Normal, No(t)
   Absent), (S2: Normal, No(t) Distant, No(t) Loud, No(t) Widely split ,
   No(t) Fixed), No(t) S3, No(t) S4, No(t) Rub, (Murmur: Systolic, No(t)
   Diastolic)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric, No(t) Paradoxical),
   (Percussion: Resonant : , No(t) Hyperresonant: , No(t) Dullness : ),
   (Breath Sounds: No(t) Clear : , No(t) Crackles : , No(t) Bronchial: ,
   No(t) Wheezes : , No(t) Diminished: , No(t) Absent : , Rhonchorous:
   scattered)
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended,
   No(t) Tender: , No(t) Obese
   Extremities: Right: Trace, Left: Trace, No(t) Cyanosis, No(t) Clubbing
   Musculoskeletal: Muscle wasting, Unable to stand
   Skin:  Warm, Rash: macular-papular erythematous rash over trunk, No(t)
   Jaundice
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, No(t) Oriented (to): , Movement: Purposeful, No(t) Sedated,
   No(t) Paralyzed, Tone: Normal
   Labs / Radiology
   11.9 g/dL
   296 K/uL
   90 mg/dL
   0.9 mg/dL
   26 mEq/L
   4.4 mEq/L
   12 mg/dL
   107 mEq/L
   141 mEq/L
   34.5 %
   11.4 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   Plt
   [**Telephone/Fax (3) 3174**]03
   296
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   Glucose
   90
   105
   104
   100
   90
   Other labs: Differential-Neuts:81.0 %, Band:0.0 %, Lymph:5.0 %,
   Mono:9.0 %, Eos:4.0 %, Ca++:8.7 mg/dL, Mg++:2.3 mg/dL, PO4:2.7 mg/dL
   Imaging: CT angio with no evidence for PE.  However, interval
   development of multiple densities, LLL >> RLL and mid lung zones.
   Assessment and Plan
   HYPOXEMIA -- attributed to new pneumonia on background of RSV
   infection.   No evidence for pulmonary embolism by today's CT scan.
   Evidence for new pulmonary infiltrates on right and left upper lobes
   --> possibly representing new infection or process (ex. PcP or other
   fungal infection), progression of underlying infection, complication of
   medications (ex. related to rash, related to antibody administration).
   Plan continue supplimental oxygen, monitor RR, maintain SaO2 > 90%,
   continue empirical antimicrobials.  Provide beta-agonist.  Check on
   next scheduled PcP prophylaxis Would check LE NIVS to assess for DVT.
   Check beta-galactomannan.  Consider bronchoscopy, although would
   require intubation to perform procedure safely.  Low threshold for
   intubation in event of clinical decline.
   PNEUMONIA (HAP) -- clinical variability on current regimen.  Doubt OI.
   Consider bronchoscopic investigation.  Continue current level of care.
   Interval development of multiple pulmonary infiltates  may represent
   aspiration or atuypical pneuonia, but may also represent process such
   as right-sided endovascular infeciton (ex. endocarditis, line-related
   infection).  Check blood cultures, consider repeat echo.
   RSV infection -- s/p antibody treatment.
   Cough -- attributed to RSV and HAP.  Improving.
   RASH -- new development;  appears drug-related, and currently receiving
   several potential offenders, including contrast dye (CT angio).
   CML s/p SCT c/b GVHD
 continue current level of care.
   GI GVHD -- continue oral swish and spit.
   NUTRITIONAL SUPPORT
 encourage PO with suppliments.
   DEPRESSED MOOD -- consider pharmacological  intervention.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   20 Gauge - [**2104-12-14**] 10:59 AM
   Prophylaxis:
   DVT: Boots(Systemic anticoagulation: None)
   Stress ulcer: H2 blocker
   VAP: HOB elevation
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :ICU
   Total time spent: 45 minutes
   Patient is critically ill<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the progress note, the patient is a 78-year-old male with a history of CML, s/p SCT, c/b GVHD, currently admitted to the ICU for respiratory distress. The patient has a history of RSV infection, pneumonia, and is currently being treated with empirical antimicrobials.

The patient's current condition is marked by hypoxemia, malaise, significant cough, and persistent respiratory distress. The patient has a new skin rash, erythematous macular-papular rash over the trunk and back, which is attributed to the antibiotics.

The patient's vital signs are stable, with a temperature of 36.4°C, heart rate of 104 bpm, and blood pressure of 110/66 mmHg. The patient's respiratory rate is 14 breaths per minute, and oxygen saturation is 93% on nasal cannula.

The patient's physical examination reveals a well-nourished individual with no acute distress, with normal pupils, normocephalic head, and normal breath sounds. The patient has a macular-papular rash over the trunk and back, and is unable to stand due to muscle wasting.

The patient's laboratory results show a white blood cell count of 10.3, hemoglobin of 11.9 g/dL, and platelet count of 296 K/uL. The patient's blood urea nitrogen is 26 mEq/L, and creatinine is 1.3 mg/dL.

The patient's assessment and plan include the following:

* Hypoxemia attributed to new pneumonia on background of RSV infection. The patient will continue to receive supplemental oxygen, monitor respiratory rate, and maintain oxygen saturation > 90%.
* Pneumonia (HAP) - clinical variability on current regimen. The patient will continue to receive empirical antimicrobials, and bronchoscopic investigation is being considered.
* RSV infection - s/p antibody treatment. The patient will continue to receive treatment for RSV infection.
* Rash - new development, appears drug-related, and currently receiving several potential offenders, including contrast dye (CT angio).

Potential medical complications that can arise include:

* Progressive respiratory failure
* Pneumonia (HAP) progression
* RSV infection reactivation
* GVHD progression
* Line-related infections (e.g., endocarditis, line-related infection)
* Atypical pneumonia or aspiration pneumonia
* Endovascular infection (e.g., right-sided endovascular infection)

The patient's condition is critical, and close monitoring is necessary to prevent and manage potential complications."
101091.0,273922,2104-12-15 05:44:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 TUNNELED (HICKMAN) LINE - START [**2104-12-14**] 10:58 AM
 BLOOD CULTURED - At [**2104-12-14**] 04:45 PM
   1x1 . Sample drawn from Hickmann
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Aztreonam - [**2104-12-15**] 12:20 AM
   Linezolid - [**2104-12-15**] 04:00 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2104-12-14**] 08:40 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-15**] 05:43 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.7
C (98
   HR: 88 (84 - 108) bpm
   BP: 92/58(66) {90/52(62) - 129/79(90)} mmHg
   RR: 21 (14 - 26) insp/min
   SpO2: 93%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    570 mL
                                                                    407 mL
   PO:
                                                                    340 mL
                                                                    250 mL
   TF:
   IVF:
                                                                    230 mL
                                                                    157 mL
   Blood products:
   Total out:
                                                                    400 mL
                                                                    550 mL
   Urine:
                                                                    400 mL
                                                                    550 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    170 mL
                                                                   -143 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 93%
   ABG: ///30/
   Physical Examination
   General Appearance: Well nourished, No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (PMI Normal), (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Bronchial:
   , Rhonchorous: )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm, Rash: diffuse maculopapular over torso and neck
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Oriented (to): person, place, time, Movement: Not assessed,
   Tone: Not assessed
   Labs / Radiology
   329 K/uL
   11.1 g/dL
   101 mg/dL
   1.0 mg/dL
   30 mEq/L
   4.0 mEq/L
   10 mg/dL
   105 mEq/L
   142 mEq/L
   33.9 %
   13.6 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   Plt
   [**Telephone/Fax (2) 3249**]
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   Other labs: Differential-Neuts:81.0 %, Band:0.0 %, Lymph:5.0 %,
   Mono:9.0 %, Eos:4.0 %, Ca++:8.9 mg/dL, Mg++:1.9 mg/dL, PO4:3.6 mg/dL
   Assessment and Plan
   55 yo M with h/o CML s/p MRD allo-SCT c/b GVHD of skin/gut on
   immunosuppression presenting with RSV bronchiolitis c/b hospital
   acquired pneumonia, now with acute hypoxia.
   .
   # Hypoxia: Appears to have been acute in onset, patient without any
   major complaints at the time.  ABG showing PaO2 of 65.  Differential
   includes PE, COPD exacerbation, worsening pneumonia or fungal
   infection, worsening bronchiolitis.  Also possible endovascular issue
   given indwelling line (Hickman) and multifocal pneumonia).Patient did
   have a CTA on [**12-5**] showing stable emphysema and no evidence of PE.
   Additionally, patient rapidly improved his oxygenation from requiring a
   NRB to maintaining sats in the mid-90s on 6L NC after receiving
   nebulizer treatments.  CXR wtihout any acute change from prior.
   Patient feels well except for ongoing cough
   - CTA now - prelim read: no e/o PE, but LLL infiltrate as well as new
   foci of infiltrate in LUL and RUL concerning for fungal or other
   organism.
   - Follow up final read CT
   - Continue ATC nebulizer treatment and prn albuterol
   - Continue to wean oxygen as needed
   - Continue broad spectrum abx with vanc/cefepime.  Also receiving
   posaconazole ppx, gets pentamidine as outpatient, will check date.
   Patient with no atypical coverage at this time, will discuss with ID as
   below.
   - Contact ID re: abx recommendations as patient is on broad spectrum
   and fungal coverage
   - Consider bronchoscopy for further characterization of infectious
   process, patient will likely need to be intubated for procedure.
   - Blood cultures with spikes, ECHO if cultures positive
   .
   # CML s/p transplant and GVHD: continue immunosuppression as per BMT
   team with prednisone, neoral and cellcept.  Picture not consistent with
   PCP. [**Name Initial (NameIs) 3160**]/galactomannan negative, and given posaconazole
   prophylaxis, unlikely aspergillus pneumonia.
   - Dexamethasone s/s for oral GVHD.
   - Continue current prophylactic agents with posaconazole and acyclovir.
   Received inhaled pentamidine as outpatient.
   - Continue ursodiol.
   .
   # Rash: Appears to be drug induced.  Unclear when rash began, though it
   appears to be new today.  Patient does not recall having had it prior,
   and nursing from BMT floor did not report it to nursing.  Cause
   includes drug-induced from cefepime (patient is allergic to pen VK -
   will clarify if reaction was a rash) though he has been on this
   multiple times in the past.  Also could be secondary to IV contrast
   though from CTA today as nursing does not think rash was present prior,
   though he has had IV contrast in the past as well.  No other apparent
   new drugs
   - Will continue to monitor
   - Symptomatic treatment if necessary including benadryl, H2 blocker,
   increase steroids
   .
   # Cardiomyopathy: continue outpatient metoprolol XL. Unlikely that his
   hypoxia is related to ACS as it improved with nebulizers.  No
   PND/orthopnea or other signs of decompensated heart failure.
   - Check ECG now
   .
   # FEN: cardiac diet, follow/replete electrolytes, continue standing
   magnesium repletion.
   .
   # Communication: [**First Name8 (NamePattern2) 3094**] [**Last Name (NamePattern1) 3231**] (daughter) [**Telephone/Fax (1) 3232**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 TUNNELED (HICKMAN) LINE - START [**2104-12-14**] 10:58 AM
 BLOOD CULTURED - At [**2104-12-14**] 04:45 PM
   1x1 . Sample drawn from Hickmann
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Aztreonam - [**2104-12-15**] 12:20 AM
   Linezolid - [**2104-12-15**] 04:00 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2104-12-14**] 08:40 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-15**] 05:43 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.7
C (98
   HR: 88 (84 - 108) bpm
   BP: 92/58(66) {90/52(62) - 129/79(90)} mmHg
   RR: 21 (14 - 26) insp/min
   SpO2: 93%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    570 mL
                                                                    407 mL
   PO:
                                                                    340 mL
                                                                    250 mL
   TF:
   IVF:
                                                                    230 mL
                                                                    157 mL
   Blood products:
   Total out:
                                                                    400 mL
                                                                    550 mL
   Urine:
                                                                    400 mL
                                                                    550 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    170 mL
                                                                   -143 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 93%
   ABG: ///30/
   Physical Examination
   General Appearance: Well nourished, No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (PMI Normal), (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Bronchial:
   , Rhonchorous: )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm, Rash: diffuse maculopapular over torso and neck
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Oriented (to): person, place, time, Movement: Not assessed,
   Tone: Not assessed
   Labs / Radiology
   329 K/uL
   11.1 g/dL
   101 mg/dL
   1.0 mg/dL
   30 mEq/L
   4.0 mEq/L
   10 mg/dL
   105 mEq/L
   142 mEq/L
   33.9 %
   13.6 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   Plt
   [**Telephone/Fax (2) 3249**]
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   Other labs: Differential-Neuts:81.0 %, Band:0.0 %, Lymph:5.0 %,
   Mono:9.0 %, Eos:4.0 %, Ca++:8.9 mg/dL, Mg++:1.9 mg/dL, PO4:3.6 mg/dL
   Assessment and Plan
   55 yo M with h/o CML s/p MRD allo-SCT c/b GVHD of skin/gut on
   immunosuppression presenting with RSV bronchiolitis c/b hospital
   acquired pneumonia, now with acute hypoxia.
   .
   # Hypoxia: Appears to have been acute in onset, patient without any
   major complaints at the time.  ABG showing PaO2 of 65.  Differential
   includes PE, COPD exacerbation, worsening pneumonia or fungal
   infection, worsening bronchiolitis.  Also possible endovascular issue
   given indwelling line (Hickman) and multifocal pneumonia).Patient did
   have a CTA on [**12-5**] showing stable emphysema and no evidence of PE.
   Additionally, patient rapidly improved his oxygenation from requiring a
   NRB to maintaining sats in the mid-90s on 6L NC after receiving
   nebulizer treatments.  CXR wtihout any acute change from prior.
   Patient feels well except for ongoing cough
   - CTA now - prelim read: no e/o PE, but LLL infiltrate as well as new
   foci of infiltrate in LUL and RUL concerning for fungal or other
   organism.
   - Follow up final read CT
   - Continue ATC nebulizer treatment and prn albuterol
   - Continue to wean oxygen as needed
   - Continue broad spectrum abx with vanc/cefepime.  Also receiving
   posaconazole ppx, gets pentamidine as outpatient, will check date.
   Patient with no atypical coverage at this time, will discuss with ID as
   below.
   - Contact ID re: abx recommendations as patient is on broad spectrum
   and fungal coverage
   - Consider bronchoscopy for further characterization of infectious
   process, patient will likely need to be intubated for procedure.
   - Blood cultures with spikes, ECHO if cultures positive
   .
   # CML s/p transplant and GVHD: continue immunosuppression as per BMT
   team with prednisone, neoral and cellcept.  Picture not consistent with
   PCP. [**Name Initial (NameIs) 3160**]/galactomannan negative, and given posaconazole
   prophylaxis, unlikely aspergillus pneumonia.
   - Dexamethasone s/s for oral GVHD.
   - Continue current prophylactic agents with posaconazole and acyclovir.
   Received inhaled pentamidine as outpatient.
   - Continue ursodiol.
   .
   # Rash: Appears to be drug induced.  Unclear when rash began, though it
   appears to be new today.  Patient does not recall having had it prior,
   and nursing from BMT floor did not report it to nursing.  Cause
   includes drug-induced from cefepime (patient is allergic to pen VK -
   will clarify if reaction was a rash) though he has been on this
   multiple times in the past.  Also could be secondary to IV contrast
   though from CTA today as nursing does not think rash was present prior,
   though he has had IV contrast in the past as well.  No other apparent
   new drugs
   - Will continue to monitor
   - Symptomatic treatment if necessary including benadryl, H2 blocker,
   increase steroids
   .
   # Cardiomyopathy: continue outpatient metoprolol XL. Unlikely that his
   hypoxia is related to ACS as it improved with nebulizers.  No
   PND/orthopnea or other signs of decompensated heart failure.
   - Check ECG now
   .
   # FEN: cardiac diet, follow/replete electrolytes, continue standing
   magnesium repletion.
   .
   # Communication: [**First Name8 (NamePattern2) 3094**] [**Last Name (NamePattern1) 3231**] (daughter) [**Telephone/Fax (1) 3232**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, I summarize the patient's health status as follows:

The patient is a 55-year-old male with a history of chronic myeloid leukemia (CML) who underwent allogenic stem cell transplantation (allo-SCT) and developed graft-versus-host disease (GVHD) of the skin and gut. He was admitted to the hospital with respiratory syncytial virus (RSV) bronchiolitis and hospital-acquired pneumonia. The patient has been treated with broad-spectrum antibiotics, including vancomycin and cefepime, and has also received posaconazole prophylaxis.

The patient's current vital signs are:

* Temperature: 37.9°C (100.2°F)
* Heart rate: 88 beats per minute (bpm)
* Blood pressure: 92/58 mmHg
* Respiratory rate: 21 breaths per minute (bpm)
* Oxygen saturation: 93%
* SpO2: 93%

The patient's laboratory results show:

* White blood cell count: 13.6 K/uL
* Hemoglobin: 11.1 g/dL
* Platelet count: 142 K/uL
* Creatinine: 1.3 mg/dL
* Glucose: 101 mg/dL
* Calcium: 8.9 mg/dL
* Magnesium: 1.9 mg/dL
* Phosphorus: 3.6 mg/dL

The patient's physical examination reveals:

* General appearance: Well-nourished, no acute distress
* Cardiovascular: Normal pulse, blood pressure, and heart rhythm
* Respiratory: Symmetric chest expansion, bronchial breath sounds, and rhonchorous
* Abdominal: Soft, non-tender, with bowel sounds present
* Skin: Warm, with a diffuse maculopapular rash over the torso and neck
* Neurologic: Attentive, follows simple commands, and responds to verbal stimuli

Potential medical complications that can arise from the patient's conditions include:

1. Respiratory failure: The patient's acute hypoxia and pneumonia may lead to respiratory failure, which could require intubation and mechanical ventilation.
2. Sepsis: The patient's sepsis and pneumonia may lead to septic shock, which could result in organ failure and death.
3. Graft-versus-host disease (GVHD): The patient's GVHD may worsen, leading to further organ damage and increased risk of mortality.
4. Infection: The patient's immunosuppression and GVHD may increase his risk of infection, which could lead to sepsis and organ failure.
5. Cardiomyopathy: The patient's cardiomyopathy may worsen, leading to heart failure and increased risk of mortality.
6. Renal failure: The patient's elevated creatinine levels may indicate renal failure, which could worsen his overall condition.
7. Electrolyte imbalance: The patient's electrolyte imbalance may lead to cardiac arrhythmias, muscle weakness, and other complications.

Based on the patient's condition, I recommend the following:

1. Continue broad-spectrum antibiotics and antifungal therapy.
2. Monitor the patient's vital signs and laboratory results closely.
3. Consider bronchoscopy to further characterize the infectious process.
4. Continue immunosuppressive therapy to manage GVHD.
5. Monitor the patient's cardiomyopathy and consider adjusting his medication regimen as necessary.
6. Continue to monitor the patient's electrolyte levels and adjust his medication regimen as necessary.
7. Consider referral to a pulmonologist or intensivist for further management of the patient's respiratory failure."
101091.0,273922,2104-12-15 05:44:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 TUNNELED (HICKMAN) LINE - START [**2104-12-14**] 10:58 AM
 BLOOD CULTURED - At [**2104-12-14**] 04:45 PM
   1x1 . Sample drawn from Hickmann
   Antibiotic regimen changed to Linezolid/Aztreonam per ID
   recommendations; also on Cipro.
   No other overnight events; pt continue to be on 6L NC.  Not complaining
   of worsening cough or SOB.  Rash appears worse but non-pruritic.
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Aztreonam - [**2104-12-15**] 12:20 AM
   Linezolid - [**2104-12-15**] 04:00 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2104-12-14**] 08:40 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-15**] 05:43 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.7
C (98
   HR: 88 (84 - 108) bpm
   BP: 92/58(66) {90/52(62) - 129/79(90)} mmHg
   RR: 21 (14 - 26) insp/min
   SpO2: 93%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    570 mL
                                                                    407 mL
   PO:
                                                                    340 mL
                                                                    250 mL
   TF:
   IVF:
                                                                    230 mL
                                                                    157 mL
   Blood products:
   Total out:
                                                                    400 mL
                                                                    550 mL
   Urine:
                                                                    400 mL
                                                                    550 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    170 mL
                                                                   -143 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula 6L
   SpO2: 93%
   ABG: ///30/
   Physical Examination
   General Appearance: Well nourished, No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (PMI Normal), (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: Crackles at both bases, R>L
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm, Rash: diffuse maculopapular over torso and neck, extending
   to lower legs and arms; all areas except face.  Rash is blanching.
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Oriented (to): person, place, time, Movement: Not assessed,
   Tone: Not assessed
   Labs / Radiology
   329 K/uL
   11.1 g/dL
   101 mg/dL
   1.0 mg/dL
   30 mEq/L
   4.0 mEq/L
   10 mg/dL
   105 mEq/L
   142 mEq/L
   33.9 %
   13.6 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   Plt
   [**Telephone/Fax (2) 3249**]
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   Other labs: Differential-Neuts:81.0 %, Band:0.0 %, Lymph:5.0 %,
   Mono:9.0 %, Eos:4.0 %, Ca++:8.9 mg/dL, Mg++:1.9 mg/dL, PO4:3.6 mg/dL
   Assessment and Plan
   55 yo M with h/o CML s/p MRD allo-SCT c/b GVHD of skin/gut on
   immunosuppression presenting with RSV bronchiolitis c/b hospital
   acquired pneumonia, now with acute hypoxia.
   .
   # Hypoxia: Improved since admission to the ICU, now on 6L NC.  Pt did
   not clearly improve after last admission so current presentation may be
   manifestation of prior RSV illness.  Chest CT with new foci of
   infiltrate in LUL and RUL although has been on broad-spectrum abx and
   antifungals.  PCP less likely given presentation although possible
   given prednisone use.
   - continue Linezolid (day #1 = [**2103-12-14**]) and Aztreonam (day #1 = [**2103-12-14**]);
   had received 7 days of Vanc/Cefepime prior to this.  Cipro started
   [**2103-12-14**] as well.
   - Continue ATC nebulizer treatment and prn albuterol
   - Continue to wean oxygen as needed
   - continue antifungals and acyclovir prophylaxis; was on pentamadine
   prior to admission for PCP prophylaxis
   [**Name Initial (PRE) **] Consider bronchoscopy for further characterization of infectious
   process, patient will likely need to be intubated for procedure.
   - Blood cultures with spikes, ECHO if cultures positive
   .
   # CML s/p transplant and GVHD: continue immunosuppression as per BMT
   team with prednisone, neoral and cellcept.  Picture not consistent with
   PCP. [**Name Initial (NameIs) 3160**]/galactomannan negative, and given posaconazole
   prophylaxis, unlikely aspergillus pneumonia.  ? if this rash is
   manifestation of GVHD as well vs. drug rash.
   - Dexamethasone s/s for oral GVHD.
   - Continue current prophylactic agents with posaconazole and acyclovir.
   Received inhaled pentamidine as outpatient.
   - Continue ursodiol.
   - discuss with BMT team utility of high dose steroids for possible GVHD
   of lung or skin
   - possible IVIG today per BMT
   .
   # Rash: Appears to be drug induced.  Appears to be new today.  Patient
   does not recall having had it prior, and nursing from BMT floor did not
   report it to nursing.  Cause includes drug-induced from cefepime
   (patient is allergic to pen VK) though he has been on this multiple
   times in the past.  Also could be secondary to IV contrast though from
   CTA yesterday as nursing does not think rash was present prior, though
   he has had IV contrast in the past as well.  No other apparent new
   drugs.  Possible GVHD as well.
   - Will continue to monitor
   - Symptomatic treatment if necessary including benadryl, H2 blocker,
   increase steroids
   .
   # Cardiomyopathy: continue outpatient metoprolol XL. Unlikely that his
   hypoxia is related to ACS as it improved with nebulizers.  No
   PND/orthopnea or other signs of decompensated heart failure.
   .
   # FEN: cardiac diet, follow/replete electrolytes, continue standing
   magnesium repletion.
   .
   # Communication: [**First Name8 (NamePattern2) 3094**] [**Last Name (NamePattern1) 3231**] (daughter) [**Telephone/Fax (1) 3232**]
   ICU Care
   Nutrition: cardiac diet
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT:  Heparin SC
   Stress ulcer:  Omeprazole 20mg PO BID
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU level of care pending possible bronch today and O2
   requirements
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 TUNNELED (HICKMAN) LINE - START [**2104-12-14**] 10:58 AM
 BLOOD CULTURED - At [**2104-12-14**] 04:45 PM
   1x1 . Sample drawn from Hickmann
   Antibiotic regimen changed to Linezolid/Aztreonam per ID
   recommendations; also on Cipro.
   No other overnight events; pt continue to be on 6L NC.  Not complaining
   of worsening cough or SOB.  Rash appears worse but non-pruritic.
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Aztreonam - [**2104-12-15**] 12:20 AM
   Linezolid - [**2104-12-15**] 04:00 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2104-12-14**] 08:40 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-15**] 05:43 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.7
C (98
   HR: 88 (84 - 108) bpm
   BP: 92/58(66) {90/52(62) - 129/79(90)} mmHg
   RR: 21 (14 - 26) insp/min
   SpO2: 93%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    570 mL
                                                                    407 mL
   PO:
                                                                    340 mL
                                                                    250 mL
   TF:
   IVF:
                                                                    230 mL
                                                                    157 mL
   Blood products:
   Total out:
                                                                    400 mL
                                                                    550 mL
   Urine:
                                                                    400 mL
                                                                    550 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    170 mL
                                                                   -143 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula 6L
   SpO2: 93%
   ABG: ///30/
   Physical Examination
   General Appearance: Well nourished, No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (PMI Normal), (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: Crackles at both bases, R>L
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm, Rash: diffuse maculopapular over torso and neck, extending
   to lower legs and arms; all areas except face.  Rash is blanching.
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Oriented (to): person, place, time, Movement: Not assessed,
   Tone: Not assessed
   Labs / Radiology
   329 K/uL
   11.1 g/dL
   101 mg/dL
   1.0 mg/dL
   30 mEq/L
   4.0 mEq/L
   10 mg/dL
   105 mEq/L
   142 mEq/L
   33.9 %
   13.6 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   Plt
   [**Telephone/Fax (2) 3249**]
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   Other labs: Differential-Neuts:81.0 %, Band:0.0 %, Lymph:5.0 %,
   Mono:9.0 %, Eos:4.0 %, Ca++:8.9 mg/dL, Mg++:1.9 mg/dL, PO4:3.6 mg/dL
   Assessment and Plan
   55 yo M with h/o CML s/p MRD allo-SCT c/b GVHD of skin/gut on
   immunosuppression presenting with RSV bronchiolitis c/b hospital
   acquired pneumonia, now with acute hypoxia.
   .
   # Hypoxia: Improved since admission to the ICU, now on 6L NC.  Pt did
   not clearly improve after last admission so current presentation may be
   manifestation of prior RSV illness.  Chest CT with new foci of
   infiltrate in LUL and RUL although has been on broad-spectrum abx and
   antifungals.  PCP less likely given presentation although possible
   given prednisone use.
   - continue Linezolid (day #1 = [**2103-12-14**]) and Aztreonam (day #1 = [**2103-12-14**]);
   had received 7 days of Vanc/Cefepime prior to this.  Cipro started
   [**2103-12-14**] as well.
   - Continue ATC nebulizer treatment and prn albuterol
   - Continue to wean oxygen as needed
   - continue antifungals and acyclovir prophylaxis; was on pentamadine
   prior to admission for PCP prophylaxis
   [**Name Initial (PRE) **] Consider bronchoscopy for further characterization of infectious
   process, patient will likely need to be intubated for procedure.
   - Blood cultures with spikes, ECHO if cultures positive
   .
   # CML s/p transplant and GVHD: continue immunosuppression as per BMT
   team with prednisone, neoral and cellcept.  Picture not consistent with
   PCP. [**Name Initial (NameIs) 3160**]/galactomannan negative, and given posaconazole
   prophylaxis, unlikely aspergillus pneumonia.  ? if this rash is
   manifestation of GVHD as well vs. drug rash.
   - Dexamethasone s/s for oral GVHD.
   - Continue current prophylactic agents with posaconazole and acyclovir.
   Received inhaled pentamidine as outpatient.
   - Continue ursodiol.
   - discuss with BMT team utility of high dose steroids for possible GVHD
   of lung or skin
   - possible IVIG today per BMT
   .
   # Rash: Appears to be drug induced.  Appears to be new today.  Patient
   does not recall having had it prior, and nursing from BMT floor did not
   report it to nursing.  Cause includes drug-induced from cefepime
   (patient is allergic to pen VK) though he has been on this multiple
   times in the past.  Also could be secondary to IV contrast though from
   CTA yesterday as nursing does not think rash was present prior, though
   he has had IV contrast in the past as well.  No other apparent new
   drugs.  Possible GVHD as well.
   - Will continue to monitor
   - Symptomatic treatment if necessary including benadryl, H2 blocker,
   increase steroids
   .
   # Cardiomyopathy: continue outpatient metoprolol XL. Unlikely that his
   hypoxia is related to ACS as it improved with nebulizers.  No
   PND/orthopnea or other signs of decompensated heart failure.
   .
   # FEN: cardiac diet, follow/replete electrolytes, continue standing
   magnesium repletion.
   .
   # Communication: [**First Name8 (NamePattern2) 3094**] [**Last Name (NamePattern1) 3231**] (daughter) [**Telephone/Fax (1) 3232**]
   ICU Care
   Nutrition: cardiac diet
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT:  Heparin SC
   Stress ulcer:  Omeprazole 20mg PO BID
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU level of care pending possible bronch today and O2
   requirements<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided physician's daily progress note, the patient is a 55-year-old male with a history of Chronic Myeloid Leukemia (CML) who underwent allogenic stem cell transplantation (allo-SCT) and developed graft-versus-host disease (GVHD) of the skin and gut. He is currently admitted to the Intensive Care Unit (ICU) due to respiratory syncytial virus (RSV) bronchiolitis and hospital-acquired pneumonia.

The patient's vital signs are stable, with a temperature of 36.7°C, heart rate of 88 beats per minute, and blood pressure of 92/58 mmHg. His oxygen saturation is 93% on a nasal cannula at 6 liters per minute. His respiratory support includes continuous positive airway pressure (CPAP) and nebulizer treatment.

The patient's laboratory results show a white blood cell count of 13.6 K/μL, hemoglobin of 11.1 g/dL, and platelet count of 329 K/μL. His liver function tests are within normal limits, and his renal function is mildly impaired. His electrolyte levels are normal, except for a slightly low potassium level.

The patient's rash is diffuse maculopapular over the torso and neck, extending to the lower legs and arms. The rash is blanching and non-pruritic. The patient is allergic to penicillin and has a history of GVHD, which may be contributing to the rash.

The patient's cardiomyopathy is stable, and he is receiving outpatient metoprolol XL. His hypoxia is unlikely related to acute coronary syndrome (ACS), as it improved with nebulizers. There is no evidence of decompensated heart failure.

The patient's fluid balance is slightly positive, with a total input of 570 mL and a total output of 550 mL. His urine output is 400 mL, and his nasogastric tube output is 340 mL.

The patient's medical team is considering bronchoscopy to further characterize the infectious process, and he will likely need to be intubated for the procedure. They are also considering echocardiogram if the blood cultures are positive.

Potential medical complications that can arise include:

1. Pneumonia: The patient's hospital-acquired pneumonia may worsen, leading to respiratory failure.
2. Sepsis: The patient's blood cultures with spikes may indicate sepsis, which can lead to organ dysfunction and failure.
3. GVHD: The patient's GVHD may worsen, leading to skin and gut involvement, and potentially life-threatening complications.
4. Cardiomyopathy: The patient's cardiomyopathy may worsen, leading to heart failure and potentially life-threatening complications.
5. Respiratory failure: The patient's respiratory support may not be adequate, leading to respiratory failure.
6. Infection: The patient may develop new infections, such as ventilator-associated pneumonia (VAP), which can be life-threatening.

The patient's care plan includes:

1. Continue Linezolid and Aztreonam antibiotics.
2. Continue ATC nebulizer treatment and prn albuterol.
3. Continue to wean oxygen as needed.
4. Continue antifungal and acyclovir prophylaxis.
5. Consider bronchoscopy and echocardiogram.
6. Continue immunosuppression as per BMT team.
7. Monitor the patient's rash and provide symptomatic treatment if necessary.
8. Continue outpatient metoprolol XL for cardiomyopathy.
9. Continue cardiac diet and follow electrolyte levels.
10. Consider IVIG and high-dose steroids for possible GVHD of the lung or skin."
101091.0,273922,2104-12-15 10:20:00,Physician ,Physician Attending Progress Note,"Chief Complaint: hypoxemic respiratory distress
   I saw and examined the patient, and was physically present with the ICU
   Fellow for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   55 yo CML s/p MUD SCT c/b GVHD. Admitted w/ RSV bronchiolitis and resp
   distress initially to [**Hospital Unit Name 10**] in late [**11-17**], transferred to floor, then
   re-admitted to [**Hospital Unit Name 10**] [**2104-12-14**] with progressive hypoxemia (4L NC to NRB) in
   the setting of relatively new pulm infiltrate. CT chest [**12-14**] showed
   progression of multifocal infiltrates. Per ID rec's had viral work-up
   sent, IVIg started.
   24 Hour Events:
 TUNNELED (HICKMAN) LINE - START [**2104-12-14**] 10:58 AM
 BLOOD CULTURED - At [**2104-12-14**] 04:45 PM
   1x1 . Sample drawn from Hickmann
   No other events.
   History obtained from Patient
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-15**] 04:00 AM
   Aztreonam - [**2104-12-15**] 08:00 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2104-12-14**] 08:40 PM
   Heparin Sodium (Prophylaxis) - [**2104-12-15**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-15**] 10:20 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.4
C (97.6
   HR: 90 (81 - 108) bpm
   BP: 83/55(60) {83/52(60) - 129/79(90)} mmHg
   RR: 18 (14 - 26) insp/min
   SpO2: 87%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    570 mL
                                                                    696 mL
   PO:
                                                                    340 mL
                                                                    400 mL
   TF:
   IVF:
                                                                    230 mL
                                                                    296 mL
   Blood products:
   Total out:
                                                                    400 mL
                                                                    550 mL
   Urine:
                                                                    400 mL
                                                                    550 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    170 mL
                                                                    146 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 87%
   ABG: ///30/
   Physical Examination
   General Appearance: No acute distress
   Cardiovascular: (S1: Normal), (S2: Normal), no m/r/g
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: Crackles : L base)
   Abdominal: Soft, Non-tender
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed, Rash: maculopap on trunk and neck
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   11.1 g/dL
   329 K/uL
   101 mg/dL
   1.0 mg/dL
   30 mEq/L
   4.0 mEq/L
   10 mg/dL
   105 mEq/L
   142 mEq/L
   33.9 %
   13.6 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   Plt
   [**Telephone/Fax (2) 3249**]
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   Other labs: Differential-Neuts:81.0 %, Band:0.0 %, Lymph:5.0 %,
   Mono:9.0 %, Eos:4.0 %, Ca++:8.9 mg/dL, Mg++:1.9 mg/dL, PO4:3.6 mg/dL
   Fluid analysis / Other labs: galactomannan- neg
   bD-glucan- neg
   Imaging: CT Chest ([**2104-12-14**])- L apical blebs, patchy ground glass
   throughout all lobes, dense infiltrates B bases
   Microbiology: Blood- pending
   Sputum- nl flora
   Rapid viral Ag- neg
   CMV VL- pending
   Assessment and Plan
   HYPOXEMIA -- Attributed to new pneumonia on background of RSV
   infection. r/o for PE on [**12-14**] CT. DDx includes recurr bact pneumonia,
   PCP or fungal process. Also consider GVHD. Plan continue supplemental
   oxygen, monitor RR, maintain SaO2 > 90%, continue empirical
   antimicrobials.  Provide beta-agonist.  Check on next scheduled PcP
   [**Name Initial (PRE) 3261**]. Consider bronchoscopy this afternoon. Low threshold for
   intubation in event of clinical decline.
   RSV infection -- s/p antibody treatment.
   RASH -- new development;  appears drug-related, and currently receiving
   several potential offenders, including contrast dye and cefepime
   CML s/p SCT c/b GVHD
 continue current level of care. Will d/w BMT
   service re: IvIg therapy and poss modification of steroid regimem
   GI GVHD -- continue oral swish and spit.
   NUTRITIONAL SUPPORT
 encourage PO with supplements. Keep npo for poss
   bronch this pm
   DEPRESSED MOOD -- consider pharmacological  intervention.
   ICU Care
   Nutrition:
   Glycemic Control:  Blood sugar well controlled
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :ICU
   Total time spent: 50 minutes
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: hypoxemic respiratory distress
   I saw and examined the patient, and was physically present with the ICU
   Fellow for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   55 yo CML s/p MUD SCT c/b GVHD. Admitted w/ RSV bronchiolitis and resp
   distress initially to [**Hospital Unit Name 10**] in late [**11-17**], transferred to floor, then
   re-admitted to [**Hospital Unit Name 10**] [**2104-12-14**] with progressive hypoxemia (4L NC to NRB) in
   the setting of relatively new pulm infiltrate. CT chest [**12-14**] showed
   progression of multifocal infiltrates. Per ID rec's had viral work-up
   sent, IVIg started.
   24 Hour Events:
 TUNNELED (HICKMAN) LINE - START [**2104-12-14**] 10:58 AM
 BLOOD CULTURED - At [**2104-12-14**] 04:45 PM
   1x1 . Sample drawn from Hickmann
   No other events.
   History obtained from Patient
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-15**] 04:00 AM
   Aztreonam - [**2104-12-15**] 08:00 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2104-12-14**] 08:40 PM
   Heparin Sodium (Prophylaxis) - [**2104-12-15**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-15**] 10:20 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.4
C (97.6
   HR: 90 (81 - 108) bpm
   BP: 83/55(60) {83/52(60) - 129/79(90)} mmHg
   RR: 18 (14 - 26) insp/min
   SpO2: 87%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    570 mL
                                                                    696 mL
   PO:
                                                                    340 mL
                                                                    400 mL
   TF:
   IVF:
                                                                    230 mL
                                                                    296 mL
   Blood products:
   Total out:
                                                                    400 mL
                                                                    550 mL
   Urine:
                                                                    400 mL
                                                                    550 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    170 mL
                                                                    146 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 87%
   ABG: ///30/
   Physical Examination
   General Appearance: No acute distress
   Cardiovascular: (S1: Normal), (S2: Normal), no m/r/g
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: Crackles : L base)
   Abdominal: Soft, Non-tender
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed, Rash: maculopap on trunk and neck
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   11.1 g/dL
   329 K/uL
   101 mg/dL
   1.0 mg/dL
   30 mEq/L
   4.0 mEq/L
   10 mg/dL
   105 mEq/L
   142 mEq/L
   33.9 %
   13.6 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   Plt
   [**Telephone/Fax (2) 3249**]
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   Other labs: Differential-Neuts:81.0 %, Band:0.0 %, Lymph:5.0 %,
   Mono:9.0 %, Eos:4.0 %, Ca++:8.9 mg/dL, Mg++:1.9 mg/dL, PO4:3.6 mg/dL
   Fluid analysis / Other labs: galactomannan- neg
   bD-glucan- neg
   Imaging: CT Chest ([**2104-12-14**])- L apical blebs, patchy ground glass
   throughout all lobes, dense infiltrates B bases
   Microbiology: Blood- pending
   Sputum- nl flora
   Rapid viral Ag- neg
   CMV VL- pending
   Assessment and Plan
   HYPOXEMIA -- Attributed to new pneumonia on background of RSV
   infection. r/o for PE on [**12-14**] CT. DDx includes recurr bact pneumonia,
   PCP or fungal process. Also consider GVHD. Plan continue supplemental
   oxygen, monitor RR, maintain SaO2 > 90%, continue empirical
   antimicrobials.  Provide beta-agonist.  Check on next scheduled PcP
   [**Name Initial (PRE) 3261**]. Consider bronchoscopy this afternoon. Low threshold for
   intubation in event of clinical decline.
   RSV infection -- s/p antibody treatment.
   RASH -- new development;  appears drug-related, and currently receiving
   several potential offenders, including contrast dye and cefepime
   CML s/p SCT c/b GVHD
 continue current level of care. Will d/w BMT
   service re: IvIg therapy and poss modification of steroid regimem
   GI GVHD -- continue oral swish and spit.
   NUTRITIONAL SUPPORT
 encourage PO with supplements. Keep npo for poss
   bronch this pm
   DEPRESSED MOOD -- consider pharmacological  intervention.
   ICU Care
   Nutrition:
   Glycemic Control:  Blood sugar well controlled
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :ICU
   Total time spent: 50 minutes<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 55-year-old male with chronic myeloid leukemia (CML) who underwent allogenic stem cell transplantation (MUD SCT) and developed graft-versus-host disease (GVHD). The patient was initially admitted to the hospital with respiratory syncytial virus (RSV) bronchiolitis and respiratory distress, and later re-admitted with progressive hypoxemia and a new pulmonary infiltrate.

The patient's current condition is characterized by:

* Hypoxemic respiratory distress with an oxygen saturation of 87%
* Multifocal pulmonary infiltrates on CT chest
* Positive blood cultures
* Presence of a tunneled Hickman line
* History of antibiotic use, including linezolid and aztreonam
* Presence of a rash, which is suspected to be drug-related
* Depressed mood

The potential medical complications that can arise from the patient's condition include:

* Recurrent bacterial pneumonia
* Pneumocystis pneumonia (PCP)
* Fungal process
* GVHD
* Intubation
* Development of respiratory failure
* Increased risk of sepsis and septic shock

The patient is currently receiving supplemental oxygen, empirical antimicrobials, and beta-agonist therapy. The plan is to continue monitoring the patient's respiratory status and adjust therapy as necessary. The patient is also at risk for developing gastrointestinal GVHD, which will require close monitoring and potential modification of steroid regimens.

In addition, the patient has a history of CML and underwent allogenic stem cell transplantation, which may increase the risk of developing GVHD and other complications. The patient's mood is also depressed, which may require pharmacological intervention.

Overall, the patient's condition is complex and requires close monitoring and management to prevent potential complications."
101091.0,273922,2104-12-15 10:20:00,Physician ,Physician Attending Progress Note,"Chief Complaint: hypoxemic respiratory distress
   I saw and examined the patient, and was physically present with the ICU
   Fellow for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   55 yo CML s/p MUD SCT c/b GVHD. Admitted w/ RSV bronchiolitis and resp
   distress initially to [**Hospital Unit Name 10**] in late [**11-17**], transferred to floor, then
   re-admitted to [**Hospital Unit Name 10**] [**2104-12-14**] with progressive hypoxemia (4L NC to NRB) in
   the setting of relatively new pulm infiltrate. CT chest [**12-14**] showed
   progression of multifocal infiltrates. Per ID rec's had viral work-up
   sent, IVIg started.
   24 Hour Events:
 TUNNELED (HICKMAN) LINE - START [**2104-12-14**] 10:58 AM
 BLOOD CULTURED - At [**2104-12-14**] 04:45 PM
   1x1 . Sample drawn from Hickmann
   No other events.
   History obtained from Patient
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-15**] 04:00 AM
   Aztreonam - [**2104-12-15**] 08:00 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2104-12-14**] 08:40 PM
   Heparin Sodium (Prophylaxis) - [**2104-12-15**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-15**] 10:20 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.4
C (97.6
   HR: 90 (81 - 108) bpm
   BP: 83/55(60) {83/52(60) - 129/79(90)} mmHg
   RR: 18 (14 - 26) insp/min
   SpO2: 87%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    570 mL
                                                                    696 mL
   PO:
                                                                    340 mL
                                                                    400 mL
   TF:
   IVF:
                                                                    230 mL
                                                                    296 mL
   Blood products:
   Total out:
                                                                    400 mL
                                                                    550 mL
   Urine:
                                                                    400 mL
                                                                    550 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    170 mL
                                                                    146 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 87%
   ABG: ///30/
   Physical Examination
   General Appearance: No acute distress
   Cardiovascular: (S1: Normal), (S2: Normal), no m/r/g
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: Crackles : L base)
   Abdominal: Soft, Non-tender
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed, Rash: maculopap on trunk and neck
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   11.1 g/dL
   329 K/uL
   101 mg/dL
   1.0 mg/dL
   30 mEq/L
   4.0 mEq/L
   10 mg/dL
   105 mEq/L
   142 mEq/L
   33.9 %
   13.6 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   Plt
   [**Telephone/Fax (2) 3249**]
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   Other labs: Differential-Neuts:81.0 %, Band:0.0 %, Lymph:5.0 %,
   Mono:9.0 %, Eos:4.0 %, Ca++:8.9 mg/dL, Mg++:1.9 mg/dL, PO4:3.6 mg/dL
   Fluid analysis / Other labs: galactomannan- neg
   bD-glucan- neg
   Imaging: CT Chest ([**2104-12-14**])- L apical blebs, patchy ground glass
   throughout all lobes, dense infiltrates B bases
   Microbiology: Blood- pending
   Sputum- nl flora
   Rapid viral Ag- neg
   CMV VL- pending
   Assessment and Plan
   HYPOXEMIA -- Attributed to new pneumonia on background of RSV
   infection. r/o for PE on [**12-14**] CT. DDx includes recurr bact pneumonia,
   PCP or fungal process. Also consider GVHD. Plan continue supplemental
   oxygen, monitor RR, maintain SaO2 > 90%, continue empirical
   antimicrobials.  Provide beta-agonist.  Check on next scheduled PcP
   [**Name Initial (PRE) 3261**]. Consider bronchoscopy this afternoon. Low threshold for
   intubation in event of clinical decline.
   RSV infection -- s/p antibody treatment.
   RASH -- new development;  appears drug-related, and currently receiving
   several potential offenders, including contrast dye and cefepime
   CML s/p SCT c/b GVHD
 continue current level of care. Will d/w BMT
   service re: IvIg therapy and poss modification of steroid regimem
   GI GVHD -- continue oral swish and spit.
   NUTRITIONAL SUPPORT
 encourage PO with supplements. Keep npo for poss
   bronch this pm
   DEPRESSED MOOD -- consider pharmacological  intervention.
   ICU Care
   Nutrition:
   Glycemic Control:  Blood sugar well controlled
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :ICU
   Total time spent: 50 minutes
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: hypoxemic respiratory distress
   I saw and examined the patient, and was physically present with the ICU
   Fellow for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   55 yo CML s/p MUD SCT c/b GVHD. Admitted w/ RSV bronchiolitis and resp
   distress initially to [**Hospital Unit Name 10**] in late [**11-17**], transferred to floor, then
   re-admitted to [**Hospital Unit Name 10**] [**2104-12-14**] with progressive hypoxemia (4L NC to NRB) in
   the setting of relatively new pulm infiltrate. CT chest [**12-14**] showed
   progression of multifocal infiltrates. Per ID rec's had viral work-up
   sent, IVIg started.
   24 Hour Events:
 TUNNELED (HICKMAN) LINE - START [**2104-12-14**] 10:58 AM
 BLOOD CULTURED - At [**2104-12-14**] 04:45 PM
   1x1 . Sample drawn from Hickmann
   No other events.
   History obtained from Patient
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-15**] 04:00 AM
   Aztreonam - [**2104-12-15**] 08:00 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2104-12-14**] 08:40 PM
   Heparin Sodium (Prophylaxis) - [**2104-12-15**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-15**] 10:20 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.4
C (97.6
   HR: 90 (81 - 108) bpm
   BP: 83/55(60) {83/52(60) - 129/79(90)} mmHg
   RR: 18 (14 - 26) insp/min
   SpO2: 87%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    570 mL
                                                                    696 mL
   PO:
                                                                    340 mL
                                                                    400 mL
   TF:
   IVF:
                                                                    230 mL
                                                                    296 mL
   Blood products:
   Total out:
                                                                    400 mL
                                                                    550 mL
   Urine:
                                                                    400 mL
                                                                    550 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    170 mL
                                                                    146 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 87%
   ABG: ///30/
   Physical Examination
   General Appearance: No acute distress
   Cardiovascular: (S1: Normal), (S2: Normal), no m/r/g
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: Crackles : L base)
   Abdominal: Soft, Non-tender
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed, Rash: maculopap on trunk and neck
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   11.1 g/dL
   329 K/uL
   101 mg/dL
   1.0 mg/dL
   30 mEq/L
   4.0 mEq/L
   10 mg/dL
   105 mEq/L
   142 mEq/L
   33.9 %
   13.6 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   Plt
   [**Telephone/Fax (2) 3249**]
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   Other labs: Differential-Neuts:81.0 %, Band:0.0 %, Lymph:5.0 %,
   Mono:9.0 %, Eos:4.0 %, Ca++:8.9 mg/dL, Mg++:1.9 mg/dL, PO4:3.6 mg/dL
   Fluid analysis / Other labs: galactomannan- neg
   bD-glucan- neg
   Imaging: CT Chest ([**2104-12-14**])- L apical blebs, patchy ground glass
   throughout all lobes, dense infiltrates B bases
   Microbiology: Blood- pending
   Sputum- nl flora
   Rapid viral Ag- neg
   CMV VL- pending
   Assessment and Plan
   HYPOXEMIA -- Attributed to new pneumonia on background of RSV
   infection. r/o for PE on [**12-14**] CT. DDx includes recurr bact pneumonia,
   PCP or fungal process. Also consider GVHD. Plan continue supplemental
   oxygen, monitor RR, maintain SaO2 > 90%, continue empirical
   antimicrobials.  Provide beta-agonist.  Check on next scheduled PcP
   [**Name Initial (PRE) 3261**]. Consider bronchoscopy this afternoon. Low threshold for
   intubation in event of clinical decline.
   RSV infection -- s/p antibody treatment.
   RASH -- new development;  appears drug-related, and currently receiving
   several potential offenders, including contrast dye and cefepime
   CML s/p SCT c/b GVHD
 continue current level of care. Will d/w BMT
   service re: IvIg therapy and poss modification of steroid regimem
   GI GVHD -- continue oral swish and spit.
   NUTRITIONAL SUPPORT
 encourage PO with supplements. Keep npo for poss
   bronch this pm
   DEPRESSED MOOD -- consider pharmacological  intervention.
   ICU Care
   Nutrition:
   Glycemic Control:  Blood sugar well controlled
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :ICU
   Total time spent: 50 minutes<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 55-year-old male with chronic myeloid leukemia (CML) who has undergone a matched unrelated donor stem cell transplant (MUD SCT) and is experiencing graft-versus-host disease (GVHD). The patient was initially admitted to the hospital with respiratory syncytial virus (RSV) bronchiolitis and respiratory distress, and was subsequently transferred to the ICU due to progressive hypoxemia.

The patient's current condition is as follows:

* Respiratory: The patient is experiencing hypoxemic respiratory distress, with an SpO2 of 87% on nasal cannula oxygen. The chest CT scan shows multifocal infiltrates, and the patient has a new pulmonary infiltrate.
* Cardiovascular: The patient's blood pressure is 83/55 mmHg, and his heart rate is 90 bpm. His cardiac rhythm is sinus rhythm.
* Neurological: The patient's neurological status is unclear, as the note states that his responses to stimuli, movement, and tone are not assessed.
* Laboratory results: The patient's white blood cell count is 10.3 K/uL, and his platelet count is 142 K/uL. His blood urea nitrogen (BUN) is 30 mEq/L, and his creatinine is 1.3 mg/dL. His glucose level is 101 mg/dL.

The patient is receiving the following treatments:

* Oxygen therapy: The patient is receiving supplemental oxygen through a nasal cannula.
* Antibiotics: The patient is receiving empirical antimicrobial therapy, including linezolid and aztreonam.
* Heparin: The patient is receiving SQ UF heparin for DVT prophylaxis.
* PPI: The patient is receiving a proton pump inhibitor (PPI) for stress ulcer prophylaxis.
* IVIg: The patient is receiving intravenous immunoglobulin (IVIg) therapy.
* Steroids: The patient is receiving steroids for GVHD.

Potential medical complications that can arise from the patient's condition include:

* Respiratory failure: The patient's hypoxemic respiratory distress could progress to respiratory failure, which may require intubation.
* Sepsis: The patient's empirical antimicrobial therapy may not be effective against a potential bacterial infection, which could lead to sepsis.
* Gastrointestinal GVHD: The patient's GVHD could lead to gastrointestinal complications, such as diarrhea, nausea, and vomiting.
* Central nervous system (CNS) GVHD: The patient's GVHD could also affect the CNS, leading to neurological symptoms such as headaches, seizures, and altered mental status.
* Infections: The patient's immunocompromised state makes him susceptible to infections, including bacterial, viral, and fungal infections.

Based on the patient's condition and treatment plan, it is essential to continue monitoring his respiratory status, adjusting his oxygen therapy as needed, and closely watching for signs of respiratory failure. The patient's antibiotic therapy should be reassessed and adjusted based on the results of blood cultures and other diagnostic tests. Additionally, the patient's GVHD should be closely monitored, and the patient should be considered for bronchoscopy to rule out PCP or fungal infections."
101091.0,273922,2104-12-16 06:34:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   Pt was given IVIG per heme/onc for his hypogammaglobulinemia.
   Bronchoscopy not performed yesterday is scheduled for today. Pt was
   also started on flagyl for aneorobic coverage per ID recs. Yesterday am
   his rash was found to have spread to his legs and become more confluent
   on his chest.
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Aztreonam - [**2104-12-16**] 12:03 AM
   Acyclovir - [**2104-12-16**] 12:04 AM
   Metronidazole - [**2104-12-16**] 12:04 AM
   Linezolid - [**2104-12-16**] 04:00 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2104-12-16**] 12:03 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-16**] 06:30 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 37
C (98.6
   HR: 88 (81 - 103) bpm
   BP: 99/53(65) {77/42(52) - 114/75(83)} mmHg
   RR: 17 (15 - 23) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                  1,479 mL
                                                                    165 mL
   PO:
                                                                    795 mL
             TF:
   IVF:
                                                                    484 mL
                                                                    165 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                    900 mL
                                                                    400 mL
   Urine:
                                                                    900 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    579 mL
                                                                   -235 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 94%
   ABG: ///30/
   Physical Examination
   General Appearance: Well nourished, No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (PMI Normal), (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: Crackles at both bases, R>L
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm, Rash: diffuse maculopapular over torso and neck, extending
   to lower legs and arms; all areas except face.  Rash is blanching.
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Oriented (to): person, place, time, Movement: Not assessed,
   Tone: Not assessed
   Labs / Radiology
   293 K/uL
   10.6 g/dL
   110 mg/dL
   1.0 mg/dL
   30 mEq/L
   3.3 mEq/L
   14 mg/dL
   106 mEq/L
   142 mEq/L
   32.0 %
   9.0 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   Plt
   [**Telephone/Fax (2) 3249**]
   293
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   Other labs: PT / PTT / INR:12.7/45.1/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.4 mg/dL,
   Mg++:2.0 mg/dL, PO4:3.1 mg/dL
   Assessment and Plan
   55 yo M with h/o CML s/p MRD allo-SCT c/b GVHD of skin/gut on
   immunosuppression presenting with RSV bronchiolitis c/b hospital
   acquired pneumonia, now with acute hypoxia.
   .
   # Hypoxia: Improved since admission to the ICU, now on 6L NC.  Pt did
   not clearly improve after last admission so current presentation may be
   manifestation of prior RSV illness.  Chest CT with new foci of
   infiltrate in LUL and RUL although has been on broad-spectrum abx and
   antifungals.  PCP less likely given presentation although possible
   given prednisone use.
   - continue Linezolid (day #1 = [**2103-12-14**]) and Aztreonam (day #1 = [**2103-12-14**]);
   had received 7 days of Vanc/Cefepime prior to this.  Cipro started
   [**2103-12-14**] as well.
   - Continue ATC nebulizer treatment and prn albuterol
   - Continue to wean oxygen as needed
   - continue antifungals and acyclovir prophylaxis; was on pentamadine
   prior to admission for PCP prophylaxis
   [**Name Initial (PRE) **] Consider bronchoscopy for further characterization of infectious
   process, patient will likely need to be intubated for procedure.
   - Blood cultures with spikes, ECHO if cultures positive
   .
   # CML s/p transplant and GVHD: continue immunosuppression as per BMT
   team with prednisone, neoral and cellcept.  Picture not consistent with
   PCP. [**Name Initial (NameIs) 3160**]/galactomannan negative, and given posaconazole
   prophylaxis, unlikely aspergillus pneumonia.  ? if this rash is
   manifestation of GVHD as well vs. drug rash.
   - Dexamethasone s/s for oral GVHD.
   - Continue current prophylactic agents with posaconazole and acyclovir.
   Received inhaled pentamidine as outpatient.
   - Continue ursodiol.
   - discuss with BMT team utility of high dose steroids for possible GVHD
   of lung or skin
   - possible IVIG today per BMT
   .
   # Rash: Appears to be drug induced.  Appears to be new today.  Patient
   does not recall having had it prior, and nursing from BMT floor did not
   report it to nursing.  Cause includes drug-induced from cefepime
   (patient is allergic to pen VK) though he has been on this multiple
   times in the past.  Also could be secondary to IV contrast though from
   CTA yesterday as nursing does not think rash was present prior, though
   he has had IV contrast in the past as well.  No other apparent new
   drugs.  Possible GVHD as well.
   - Will continue to monitor
   - Symptomatic treatment if necessary including benadryl, H2 blocker,
   increase steroids
   .
   # Cardiomyopathy: continue outpatient metoprolol XL. Unlikely that his
   hypoxia is related to ACS as it improved with nebulizers.  No
   PND/orthopnea or other signs of decompensated heart failure.
   .
   # FEN: cardiac diet, follow/replete electrolytes, continue standing
   magnesium repletion.
   .
   # Communication: [**First Name8 (NamePattern2) 3094**] [**Last Name (NamePattern1) 3231**] (daughter) [**Telephone/Fax (1) 3232**]
   ICU Care
   Nutrition: cardiac diet
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT:  Heparin SC
   Stress ulcer:  Omeprazole 20mg PO BID
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU level of care pending possible bronch today and O2
   requirements
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   Pt was given IVIG per heme/onc for his hypogammaglobulinemia.
   Bronchoscopy not performed yesterday is scheduled for today. Pt was
   also started on flagyl for aneorobic coverage per ID recs. Yesterday am
   his rash was found to have spread to his legs and become more confluent
   on his chest.
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Aztreonam - [**2104-12-16**] 12:03 AM
   Acyclovir - [**2104-12-16**] 12:04 AM
   Metronidazole - [**2104-12-16**] 12:04 AM
   Linezolid - [**2104-12-16**] 04:00 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2104-12-16**] 12:03 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-16**] 06:30 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 37
C (98.6
   HR: 88 (81 - 103) bpm
   BP: 99/53(65) {77/42(52) - 114/75(83)} mmHg
   RR: 17 (15 - 23) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                  1,479 mL
                                                                    165 mL
   PO:
                                                                    795 mL
             TF:
   IVF:
                                                                    484 mL
                                                                    165 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                    900 mL
                                                                    400 mL
   Urine:
                                                                    900 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    579 mL
                                                                   -235 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 94%
   ABG: ///30/
   Physical Examination
   General Appearance: Well nourished, No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (PMI Normal), (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: Crackles at both bases, R>L
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm, Rash: diffuse maculopapular over torso and neck, extending
   to lower legs and arms; all areas except face.  Rash is blanching.
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Oriented (to): person, place, time, Movement: Not assessed,
   Tone: Not assessed
   Labs / Radiology
   293 K/uL
   10.6 g/dL
   110 mg/dL
   1.0 mg/dL
   30 mEq/L
   3.3 mEq/L
   14 mg/dL
   106 mEq/L
   142 mEq/L
   32.0 %
   9.0 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   Plt
   [**Telephone/Fax (2) 3249**]
   293
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   Other labs: PT / PTT / INR:12.7/45.1/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.4 mg/dL,
   Mg++:2.0 mg/dL, PO4:3.1 mg/dL
   Assessment and Plan
   55 yo M with h/o CML s/p MRD allo-SCT c/b GVHD of skin/gut on
   immunosuppression presenting with RSV bronchiolitis c/b hospital
   acquired pneumonia, now with acute hypoxia.
   .
   # Hypoxia: Improved since admission to the ICU, now on 6L NC.  Pt did
   not clearly improve after last admission so current presentation may be
   manifestation of prior RSV illness.  Chest CT with new foci of
   infiltrate in LUL and RUL although has been on broad-spectrum abx and
   antifungals.  PCP less likely given presentation although possible
   given prednisone use.
   - continue Linezolid (day #1 = [**2103-12-14**]) and Aztreonam (day #1 = [**2103-12-14**]);
   had received 7 days of Vanc/Cefepime prior to this.  Cipro started
   [**2103-12-14**] as well.
   - Continue ATC nebulizer treatment and prn albuterol
   - Continue to wean oxygen as needed
   - continue antifungals and acyclovir prophylaxis; was on pentamadine
   prior to admission for PCP prophylaxis
   [**Name Initial (PRE) **] Consider bronchoscopy for further characterization of infectious
   process, patient will likely need to be intubated for procedure.
   - Blood cultures with spikes, ECHO if cultures positive
   .
   # CML s/p transplant and GVHD: continue immunosuppression as per BMT
   team with prednisone, neoral and cellcept.  Picture not consistent with
   PCP. [**Name Initial (NameIs) 3160**]/galactomannan negative, and given posaconazole
   prophylaxis, unlikely aspergillus pneumonia.  ? if this rash is
   manifestation of GVHD as well vs. drug rash.
   - Dexamethasone s/s for oral GVHD.
   - Continue current prophylactic agents with posaconazole and acyclovir.
   Received inhaled pentamidine as outpatient.
   - Continue ursodiol.
   - discuss with BMT team utility of high dose steroids for possible GVHD
   of lung or skin
   - possible IVIG today per BMT
   .
   # Rash: Appears to be drug induced.  Appears to be new today.  Patient
   does not recall having had it prior, and nursing from BMT floor did not
   report it to nursing.  Cause includes drug-induced from cefepime
   (patient is allergic to pen VK) though he has been on this multiple
   times in the past.  Also could be secondary to IV contrast though from
   CTA yesterday as nursing does not think rash was present prior, though
   he has had IV contrast in the past as well.  No other apparent new
   drugs.  Possible GVHD as well.
   - Will continue to monitor
   - Symptomatic treatment if necessary including benadryl, H2 blocker,
   increase steroids
   .
   # Cardiomyopathy: continue outpatient metoprolol XL. Unlikely that his
   hypoxia is related to ACS as it improved with nebulizers.  No
   PND/orthopnea or other signs of decompensated heart failure.
   .
   # FEN: cardiac diet, follow/replete electrolytes, continue standing
   magnesium repletion.
   .
   # Communication: [**First Name8 (NamePattern2) 3094**] [**Last Name (NamePattern1) 3231**] (daughter) [**Telephone/Fax (1) 3232**]
   ICU Care
   Nutrition: cardiac diet
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT:  Heparin SC
   Stress ulcer:  Omeprazole 20mg PO BID
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU level of care pending possible bronch today and O2
   requirements<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 55-year-old male with a history of Chronic Myeloid Leukemia (CML) who underwent allogenic stem cell transplantation (allo-SCT) and is experiencing graft-versus-host disease (GVHD) of the skin and gut. He was admitted to the ICU with respiratory syncytial virus (RSV) bronchiolitis and hospital-acquired pneumonia.

The patient's current condition is as follows:

* Vital signs: T = 98.6°F, HR = 88 bpm, BP = 99/53 mmHg, RR = 17 breaths per minute, SpO2 = 94%
* Respiratory support: Oxygen therapy via nasal cannula at 6 liters per minute
* Chest CT scan reveals new foci of infiltrate in the left upper and right upper lobes
* Laboratory results: WBC = 10.3, Hct = 34.7, Plt = 293, Cr = 1.3, Glucose = 90
* Skin: Rash is diffuse maculopapular over the torso and neck, extending to the lower legs and arms, and is blanching
* Neurologic: Attentive, follows simple commands, responds to verbal stimuli, and is oriented to person, place, and time

The patient is being treated with the following medications:

* Linezolid
* Aztreonam
* Cipro
* ATC nebulizer treatment
* Prn albuterol
* Antifungals and acyclovir prophylaxis
* Prednisone
* Neoral
* Cellcept
* Posaconazole
* Dexamethasone
* Ursodiol

The patient's potential medical complications include:

* Worsening of hypoxia
* Development of acute respiratory distress syndrome (ARDS)
* Progression of pneumonia
* Sepsis
* Graft-versus-host disease (GVHD) of the lung or skin
* Cardiomyopathy
* Electrolyte imbalance
* Renal failure

The patient's code status is full code, and his disposition is ICU level of care pending possible bronchoscopy today and oxygen requirements."
101091.0,273922,2104-12-16 06:34:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   -Pt was given IVIG per heme/onc for his hypogammaglobulinemia.
   -Pt was also started on flagyl for aneorobic coverage per ID recs.
   -Yesterday am his rash was found to have spread to his legs and become
   more confluent on his chest.
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Aztreonam - [**2104-12-16**] 12:03 AM
   Acyclovir - [**2104-12-16**] 12:04 AM
   Metronidazole - [**2104-12-16**] 12:04 AM
   Linezolid - [**2104-12-16**] 04:00 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2104-12-16**] 12:03 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-16**] 06:30 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 37
C (98.6
   HR: 88 (81 - 103) bpm
   BP: 99/53(65) {77/42(52) - 114/75(83)} mmHg
   RR: 17 (15 - 23) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                  1,479 mL
                                                                    165 mL
   PO:
                                                                    795 mL
             TF:
   IVF:
                                                                    484 mL
                                                                    165 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                    900 mL
                                                                    400 mL
   Urine:
                                                                    900 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    579 mL
                                                                   -235 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 94%
   ABG: ///30/
   Physical Examination
   General Appearance: Well nourished, No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (PMI Normal), (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: Diminshed BS noted diffusely over lung fields,
   Crackles at right base
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm, Rash: diffuse maculopapular over torso, back and neck,
   extending to lower legs and arms; all areas except face.  Rash is
   blanching.
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Oriented (to): person, place, time, Movement: Not assessed,
   Tone: Not assessed
   Labs / Radiology
   293 K/uL
   10.6 g/dL
   110 mg/dL
   1.0 mg/dL
   30 mEq/L
   3.3 mEq/L
   14 mg/dL
   106 mEq/L
   142 mEq/L
   32.0 %
   9.0 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   Plt
   [**Telephone/Fax (3) 3249**]
   293
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   Other labs: PT / PTT / INR:12.7/45.1/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.4 mg/dL,
   Mg++:2.0 mg/dL, PO4:3.1 mg/dL
   Assessment and Plan
   55 yo M with h/o CML s/p MRD allo-SCT c/b GVHD of skin/gut on
   immunosuppression presenting with RSV bronchiolitis c/b hospital
   acquired pneumonia, now with acute hypoxia.
   .
   # Hypoxia: Improved since admission to the ICU, now on 6L NC.  Pt did
   not clearly improve after last admission so current presentation may be
   manifestation of prior RSV illness.  Portable chest x-ray performed
   yesterday showed pneumonia to be resolving. Pt has been afebrile and
   his leukocytosis appears to be improving on his current antibiotic
   regimen. Will defer from bronchoscopy given his current improvement in
   clinical status on his current antibiotics. Will reimage tomorrow
   morning to assess PNA progress.
    - continue Linezolid (day #1 = [**2103-12-14**]) and Aztreonam (day #1 =
   [**2103-12-14**]); had received 7 days of Vanc/Cefepime prior to this.  Cipro
   started [**2103-12-14**] as well.
   - Repeat CXR Port in the AM
   - Continue ATC nebulizer treatment and prn albuterol
   - Continue to wean oxygen as needed
   - continue antifungals and acyclovir prophylaxis; was on pentamadine
   prior to admission for PCP prophylaxis
   [**Name Initial (PRE) **] [**Name9 (PRE) 229**] cultures with spikes, ECHO if cultures positive
   .
   # CML s/p transplant and GVHD: Pt received IVIG yesterday per heme/onc
   recommendations.  No additional recs noted this morning with continue
   current immunosuppression regimen.
   - Dexamethasone s/s for oral GVHD.
   - Continue current prophylactic agents with posaconazole and acyclovir.
   Received inhaled pentamidine as outpatient.
   - Continue ursodiol.
   .
   # Rash: Appears to be drug induced, may be related to Cefepime as he
   does have an allergy history to PCN V however he has received Cefepime
   in the past without any reactions.   Appears to be new today.  Patient
   does not recall having had it prior, and nursing from BMT floor did not
   report it to nursing.  Cause includes drug-induced from cefepime
   (patient is allergic to pen VK) though he has been on this multiple
   times in the past.  Also could be secondary to IV contrast though from
   CTA yesterday as nursing does not think rash was present prior, though
   he has had IV contrast in the past as well.  No other apparent new
   drugs.  Possible GVHD as well.
   - Will continue to monitor
   - Symptomatic treatment if necessary including benadryl, H2 blocker,
   increase steroids
   .
   # Cardiomyopathy: continue outpatient metoprolol XL. Unlikely that his
   hypoxia is related to ACS as it improved with nebulizers.  No
   PND/orthopnea or other signs of decompensated heart failure.
   .
   # FEN: cardiac diet, follow/replete electrolytes, continue standing
   magnesium repletion.
   .
   # Communication: [**First Name8 (NamePattern2) 3094**] [**Last Name (NamePattern1) 3231**] (daughter) [**Telephone/Fax (1) 3232**]
   ICU Care
   Nutrition: cardiac diet
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT:  Heparin SC
   Stress ulcer:  Omeprazole 20mg PO BID
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU level of care pending possible bronch today and O2
   requirements
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   -Pt was given IVIG per heme/onc for his hypogammaglobulinemia.
   -Pt was also started on flagyl for aneorobic coverage per ID recs.
   -Yesterday am his rash was found to have spread to his legs and become
   more confluent on his chest.
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Aztreonam - [**2104-12-16**] 12:03 AM
   Acyclovir - [**2104-12-16**] 12:04 AM
   Metronidazole - [**2104-12-16**] 12:04 AM
   Linezolid - [**2104-12-16**] 04:00 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2104-12-16**] 12:03 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-16**] 06:30 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 37
C (98.6
   HR: 88 (81 - 103) bpm
   BP: 99/53(65) {77/42(52) - 114/75(83)} mmHg
   RR: 17 (15 - 23) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                  1,479 mL
                                                                    165 mL
   PO:
                                                                    795 mL
             TF:
   IVF:
                                                                    484 mL
                                                                    165 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                    900 mL
                                                                    400 mL
   Urine:
                                                                    900 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    579 mL
                                                                   -235 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 94%
   ABG: ///30/
   Physical Examination
   General Appearance: Well nourished, No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (PMI Normal), (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: Diminshed BS noted diffusely over lung fields,
   Crackles at right base
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm, Rash: diffuse maculopapular over torso, back and neck,
   extending to lower legs and arms; all areas except face.  Rash is
   blanching.
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Oriented (to): person, place, time, Movement: Not assessed,
   Tone: Not assessed
   Labs / Radiology
   293 K/uL
   10.6 g/dL
   110 mg/dL
   1.0 mg/dL
   30 mEq/L
   3.3 mEq/L
   14 mg/dL
   106 mEq/L
   142 mEq/L
   32.0 %
   9.0 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   Plt
   [**Telephone/Fax (3) 3249**]
   293
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   Other labs: PT / PTT / INR:12.7/45.1/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.4 mg/dL,
   Mg++:2.0 mg/dL, PO4:3.1 mg/dL
   Assessment and Plan
   55 yo M with h/o CML s/p MRD allo-SCT c/b GVHD of skin/gut on
   immunosuppression presenting with RSV bronchiolitis c/b hospital
   acquired pneumonia, now with acute hypoxia.
   .
   # Hypoxia: Improved since admission to the ICU, now on 6L NC.  Pt did
   not clearly improve after last admission so current presentation may be
   manifestation of prior RSV illness.  Portable chest x-ray performed
   yesterday showed pneumonia to be resolving. Pt has been afebrile and
   his leukocytosis appears to be improving on his current antibiotic
   regimen. Will defer from bronchoscopy given his current improvement in
   clinical status on his current antibiotics. Will reimage tomorrow
   morning to assess PNA progress.
    - continue Linezolid (day #1 = [**2103-12-14**]) and Aztreonam (day #1 =
   [**2103-12-14**]); had received 7 days of Vanc/Cefepime prior to this.  Cipro
   started [**2103-12-14**] as well.
   - Repeat CXR Port in the AM
   - Continue ATC nebulizer treatment and prn albuterol
   - Continue to wean oxygen as needed
   - continue antifungals and acyclovir prophylaxis; was on pentamadine
   prior to admission for PCP prophylaxis
   [**Name Initial (PRE) **] [**Name9 (PRE) 229**] cultures with spikes, ECHO if cultures positive
   .
   # CML s/p transplant and GVHD: Pt received IVIG yesterday per heme/onc
   recommendations.  No additional recs noted this morning with continue
   current immunosuppression regimen.
   - Dexamethasone s/s for oral GVHD.
   - Continue current prophylactic agents with posaconazole and acyclovir.
   Received inhaled pentamidine as outpatient.
   - Continue ursodiol.
   .
   # Rash: Appears to be drug induced, may be related to Cefepime as he
   does have an allergy history to PCN V however he has received Cefepime
   in the past without any reactions.   Appears to be new today.  Patient
   does not recall having had it prior, and nursing from BMT floor did not
   report it to nursing.  Cause includes drug-induced from cefepime
   (patient is allergic to pen VK) though he has been on this multiple
   times in the past.  Also could be secondary to IV contrast though from
   CTA yesterday as nursing does not think rash was present prior, though
   he has had IV contrast in the past as well.  No other apparent new
   drugs.  Possible GVHD as well.
   - Will continue to monitor
   - Symptomatic treatment if necessary including benadryl, H2 blocker,
   increase steroids
   .
   # Cardiomyopathy: continue outpatient metoprolol XL. Unlikely that his
   hypoxia is related to ACS as it improved with nebulizers.  No
   PND/orthopnea or other signs of decompensated heart failure.
   .
   # FEN: cardiac diet, follow/replete electrolytes, continue standing
   magnesium repletion.
   .
   # Communication: [**First Name8 (NamePattern2) 3094**] [**Last Name (NamePattern1) 3231**] (daughter) [**Telephone/Fax (1) 3232**]
   ICU Care
   Nutrition: cardiac diet
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT:  Heparin SC
   Stress ulcer:  Omeprazole 20mg PO BID
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU level of care pending possible bronch today and O2
   requirements<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 55-year-old male with a history of chronic myeloid leukemia (CML) who underwent allogenic stem cell transplantation (allo-SCT) and developed graft-versus-host disease (GVHD) of the skin and gut. He was admitted to the ICU with respiratory syncytial virus (RSV) bronchiolitis and hospital-acquired pneumonia. He has been treated with antibiotics, antivirals, and immunosuppressive therapy. The patient's current condition is characterized by acute hypoxia, which has improved with oxygen therapy. He has also developed a diffuse maculopapular rash, which is thought to be drug-induced, possibly related to cefepime or IV contrast. The patient's laboratory results show leukocytosis, anemia, and thrombocytopenia.

Potential medical complications:

1. Pneumonia: The patient's pneumonia is resolving, but there is a risk of recurrence or development of a new infection.
2. GVHD: The patient's GVHD is ongoing, and there is a risk of exacerbation or development of new symptoms.
3. Hypoxia: The patient's acute hypoxia may worsen or persist, requiring further oxygen therapy or mechanical ventilation.
4. Cardiomyopathy: The patient's cardiomyopathy may worsen, requiring further management and monitoring.
5. Rash: The patient's rash may worsen or spread, requiring further treatment and monitoring.
6. Infections: The patient is at risk of developing new infections, particularly respiratory and urinary tract infections.
7. Bleeding: The patient's thrombocytopenia may increase the risk of bleeding, particularly with invasive procedures or trauma.
8. Electrolyte imbalance: The patient's electrolyte imbalance may worsen, requiring further management and monitoring.
9. Kidney injury: The patient's kidney function may worsen, requiring further management and monitoring.

Plan:

1. Continue antibiotics and antivirals as prescribed.
2. Monitor the patient's oxygen saturation and adjust oxygen therapy as needed.
3. Continue immunosuppressive therapy as prescribed.
4. Monitor the patient's rash and adjust treatment as needed.
5. Continue to monitor the patient's laboratory results, including complete blood count, electrolyte levels, and liver function tests.
6. Consider bronchoscopy to evaluate the patient's respiratory status and rule out new infections.
7. Continue to educate the patient and his family on his condition, treatment options, and potential complications.
8. Collaborate with the patient's primary care physician and other healthcare providers to ensure comprehensive care."
101091.0,273922,2104-12-16 06:34:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   -Pt was given IVIG per heme/onc for his hypogammaglobulinemia.
   -Pt was also started on flagyl for aneorobic coverage per ID recs.
   -Yesterday am his rash was found to have spread to his legs and become
   more confluent on his chest.
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Aztreonam - [**2104-12-16**] 12:03 AM
   Acyclovir - [**2104-12-16**] 12:04 AM
   Metronidazole - [**2104-12-16**] 12:04 AM
   Linezolid - [**2104-12-16**] 04:00 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2104-12-16**] 12:03 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-16**] 06:30 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 37
C (98.6
   HR: 88 (81 - 103) bpm
   BP: 99/53(65) {77/42(52) - 114/75(83)} mmHg
   RR: 17 (15 - 23) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                  1,479 mL
                                                                    165 mL
   PO:
                                                                    795 mL
             TF:
   IVF:
                                                                    484 mL
                                                                    165 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                    900 mL
                                                                    400 mL
   Urine:
                                                                    900 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    579 mL
                                                                   -235 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 94%
   ABG: ///30/
   Physical Examination
   General Appearance: Well nourished, No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (PMI Normal), (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: Diminshed BS noted diffusely over lung fields,
   Crackles at right base
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm, Rash: diffuse maculopapular over torso, back and neck,
   extending to lower legs and arms; all areas except face.  Rash is
   blanching.
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Oriented (to): person, place, time, Movement: Not assessed,
   Tone: Not assessed
   Labs / Radiology
   293 K/uL
   10.6 g/dL
   110 mg/dL
   1.0 mg/dL
   30 mEq/L
   3.3 mEq/L
   14 mg/dL
   106 mEq/L
   142 mEq/L
   32.0 %
   9.0 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   Plt
   [**Telephone/Fax (3) 3249**]
   293
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   Other labs: PT / PTT / INR:12.7/45.1/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.4 mg/dL,
   Mg++:2.0 mg/dL, PO4:3.1 mg/dL
   Assessment and Plan
   55 yo M with h/o CML s/p MRD allo-SCT c/b GVHD of skin/gut on
   immunosuppression presenting with RSV bronchiolitis c/b hospital
   acquired pneumonia, now with acute hypoxia.
   .
   # Hypoxia: Improved since admission to the ICU, now on 6L NC.  Pt did
   not clearly improve after last admission so current presentation may be
   manifestation of prior RSV illness.  Portable chest x-ray performed
   yesterday showed pneumonia to be resolving. Pt has been afebrile and
   his leukocytosis appears to be improving on his current antibiotic
   regimen. Will defer from bronchoscopy given his current improvement in
   clinical status on his current antibiotics.
    - continue Linezolid (day #1 = [**2103-12-14**]) and Aztreonam (day #1 =
   [**2103-12-14**]); had received 7 days of Vanc/Cefepime prior to this.  Cipro
   started [**2103-12-14**] as well.
   - Continue ATC nebulizer treatment and prn albuterol
   - Continue to wean oxygen as needed
   - continue antifungals and acyclovir prophylaxis; was on pentamadine
   prior to admission for PCP prophylaxis
   [**Name Initial (PRE) **] [**Name9 (PRE) 229**] cultures with spikes, ECHO if cultures positive
   .
   # CML s/p transplant and GVHD: Pt received IVIG yesterday per heme/onc
   recommendations.  No additional recs noted this morning with continue
   current immunosuppression regimen.
   - Dexamethasone s/s for oral GVHD.
   - Continue current prophylactic agents with posaconazole and acyclovir.
   Received inhaled pentamidine as outpatient.
   - Continue ursodiol.
   .
   # Rash: Appears to be drug induced, may be related to Cefepime as he
   does have an allergy history to PCN V however he has received Cefepime
   in the past without any reactions.   Appears to be new today.  Patient
   does not recall having had it prior, and nursing from BMT floor did not
   report it to nursing.  Cause includes drug-induced from cefepime
   (patient is allergic to pen VK) though he has been on this multiple
   times in the past.  Also could be secondary to IV contrast though from
   CTA yesterday as nursing does not think rash was present prior, though
   he has had IV contrast in the past as well.  No other apparent new
   drugs.  Possible GVHD as well.
   - Will continue to monitor
   - Symptomatic treatment if necessary including benadryl, H2 blocker,
   increase steroids
   .
   # Cardiomyopathy: continue outpatient metoprolol XL. Unlikely that his
   hypoxia is related to ACS as it improved with nebulizers.  No
   PND/orthopnea or other signs of decompensated heart failure.
   .
   # FEN: cardiac diet, follow/replete electrolytes, continue standing
   magnesium repletion.
   .
   # Communication: [**First Name8 (NamePattern2) 3094**] [**Last Name (NamePattern1) 3231**] (daughter) [**Telephone/Fax (1) 3232**]
   ICU Care
   Nutrition: cardiac diet
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT:  Heparin SC
   Stress ulcer:  Omeprazole 20mg PO BID
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU level of care pending possible bronch today and O2
   requirements
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   -Pt was given IVIG per heme/onc for his hypogammaglobulinemia.
   -Pt was also started on flagyl for aneorobic coverage per ID recs.
   -Yesterday am his rash was found to have spread to his legs and become
   more confluent on his chest.
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Aztreonam - [**2104-12-16**] 12:03 AM
   Acyclovir - [**2104-12-16**] 12:04 AM
   Metronidazole - [**2104-12-16**] 12:04 AM
   Linezolid - [**2104-12-16**] 04:00 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2104-12-16**] 12:03 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-16**] 06:30 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 37
C (98.6
   HR: 88 (81 - 103) bpm
   BP: 99/53(65) {77/42(52) - 114/75(83)} mmHg
   RR: 17 (15 - 23) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                  1,479 mL
                                                                    165 mL
   PO:
                                                                    795 mL
             TF:
   IVF:
                                                                    484 mL
                                                                    165 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                    900 mL
                                                                    400 mL
   Urine:
                                                                    900 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    579 mL
                                                                   -235 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 94%
   ABG: ///30/
   Physical Examination
   General Appearance: Well nourished, No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (PMI Normal), (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: Diminshed BS noted diffusely over lung fields,
   Crackles at right base
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm, Rash: diffuse maculopapular over torso, back and neck,
   extending to lower legs and arms; all areas except face.  Rash is
   blanching.
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Oriented (to): person, place, time, Movement: Not assessed,
   Tone: Not assessed
   Labs / Radiology
   293 K/uL
   10.6 g/dL
   110 mg/dL
   1.0 mg/dL
   30 mEq/L
   3.3 mEq/L
   14 mg/dL
   106 mEq/L
   142 mEq/L
   32.0 %
   9.0 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   Plt
   [**Telephone/Fax (3) 3249**]
   293
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   Other labs: PT / PTT / INR:12.7/45.1/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.4 mg/dL,
   Mg++:2.0 mg/dL, PO4:3.1 mg/dL
   Assessment and Plan
   55 yo M with h/o CML s/p MRD allo-SCT c/b GVHD of skin/gut on
   immunosuppression presenting with RSV bronchiolitis c/b hospital
   acquired pneumonia, now with acute hypoxia.
   .
   # Hypoxia: Improved since admission to the ICU, now on 6L NC.  Pt did
   not clearly improve after last admission so current presentation may be
   manifestation of prior RSV illness.  Portable chest x-ray performed
   yesterday showed pneumonia to be resolving. Pt has been afebrile and
   his leukocytosis appears to be improving on his current antibiotic
   regimen. Will defer from bronchoscopy given his current improvement in
   clinical status on his current antibiotics.
    - continue Linezolid (day #1 = [**2103-12-14**]) and Aztreonam (day #1 =
   [**2103-12-14**]); had received 7 days of Vanc/Cefepime prior to this.  Cipro
   started [**2103-12-14**] as well.
   - Continue ATC nebulizer treatment and prn albuterol
   - Continue to wean oxygen as needed
   - continue antifungals and acyclovir prophylaxis; was on pentamadine
   prior to admission for PCP prophylaxis
   [**Name Initial (PRE) **] [**Name9 (PRE) 229**] cultures with spikes, ECHO if cultures positive
   .
   # CML s/p transplant and GVHD: Pt received IVIG yesterday per heme/onc
   recommendations.  No additional recs noted this morning with continue
   current immunosuppression regimen.
   - Dexamethasone s/s for oral GVHD.
   - Continue current prophylactic agents with posaconazole and acyclovir.
   Received inhaled pentamidine as outpatient.
   - Continue ursodiol.
   .
   # Rash: Appears to be drug induced, may be related to Cefepime as he
   does have an allergy history to PCN V however he has received Cefepime
   in the past without any reactions.   Appears to be new today.  Patient
   does not recall having had it prior, and nursing from BMT floor did not
   report it to nursing.  Cause includes drug-induced from cefepime
   (patient is allergic to pen VK) though he has been on this multiple
   times in the past.  Also could be secondary to IV contrast though from
   CTA yesterday as nursing does not think rash was present prior, though
   he has had IV contrast in the past as well.  No other apparent new
   drugs.  Possible GVHD as well.
   - Will continue to monitor
   - Symptomatic treatment if necessary including benadryl, H2 blocker,
   increase steroids
   .
   # Cardiomyopathy: continue outpatient metoprolol XL. Unlikely that his
   hypoxia is related to ACS as it improved with nebulizers.  No
   PND/orthopnea or other signs of decompensated heart failure.
   .
   # FEN: cardiac diet, follow/replete electrolytes, continue standing
   magnesium repletion.
   .
   # Communication: [**First Name8 (NamePattern2) 3094**] [**Last Name (NamePattern1) 3231**] (daughter) [**Telephone/Fax (1) 3232**]
   ICU Care
   Nutrition: cardiac diet
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT:  Heparin SC
   Stress ulcer:  Omeprazole 20mg PO BID
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU level of care pending possible bronch today and O2
   requirements<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 55-year-old male with a history of chronic myeloid leukemia (CML) who underwent allogenic stem cell transplantation (allo-SCT) and developed graft-versus-host disease (GVHD) of the skin and gut. He was admitted to the intensive care unit (ICU) with respiratory syncytial virus (RSV) bronchiolitis and hospital-acquired pneumonia. He has been receiving various medications, including antibiotics, antifungals, and immunosuppressants. His current condition includes hypoxia, leukocytosis, and a diffuse maculopapular rash.

Potential Medical Complications:

1. Respiratory failure: The patient's hypoxia may worsen, leading to respiratory failure, which could require mechanical ventilation.
2. Infection: The patient is at risk of developing secondary infections, particularly pneumonia, due to his immunocompromised state and prolonged hospitalization.
3. Cardiac complications: The patient's cardiomyopathy may worsen, leading to cardiac failure, arrhythmias, or even cardiac arrest.
4. Gastrointestinal complications: The patient's GVHD may lead to gastrointestinal bleeding, perforation, or obstruction.
5. Neurological complications: The patient's leukocytosis and immunosuppressive therapy may increase the risk of neurological complications, such as seizures, encephalopathy, or meningitis.
6. Hemorrhagic complications: The patient's thrombocytopenia may increase the risk of bleeding, particularly in the context of invasive procedures or surgical interventions.
7. Kidney injury: The patient's acute kidney injury may worsen, leading to chronic kidney disease or end-stage renal disease.
8. Liver dysfunction: The patient's liver function may deteriorate, leading to liver failure or encephalopathy.
9. Skin complications: The patient's rash may worsen, leading to skin necrosis, bullae, or secondary infections.
10. Medication-related complications: The patient's complex medication regimen may lead to adverse effects, such as anaphylaxis, Stevens-Johnson syndrome, or drug-induced liver injury.

Given the patient's complex medical condition and multiple comorbidities, it is essential to closely monitor his vital signs, laboratory results, and clinical status to prevent or promptly manage potential complications."
101091.0,273922,2104-12-16 10:36:00,Physician ,Physician Attending Progress Note,"Chief Complaint: PNA, RSV Bronchiolitis, Hypoxia
   I saw and examined the patient, and was physically present with the ICU
   Fellow for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   IV IG last PM, started on Flagyl. Rash is spreading despite stopping
   Cefopime, continuing on 6 liters. WBC down significantly. Afebrile last
   24 hrs
   History obtained from Patient
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-16**] 04:00 AM
   Aztreonam - [**2104-12-16**] 08:00 AM
   Acyclovir - [**2104-12-16**] 08:00 AM
   Metronidazole - [**2104-12-16**] 08:00 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2104-12-16**] 08:00 AM
   Omeprazole (Prilosec) - [**2104-12-16**] 08:00 AM
   Other medications:
   nebs q6, prednisone, hep SQ, dexamethasone swish and spit, MVI, Mag OX,
   Vit D, CaCO3, Vit C, Ursadiol, Ompeprazole, Cellcept, Folic A,
   Posiconizole, Cyclosporin, Acyclovir
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-16**] 10:36 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.6
C (97.8
   HR: 96 (84 - 103) bpm
   BP: 99/54(64) {77/42(52) - 118/78(86)} mmHg
   RR: 17 (15 - 23) insp/min
   SpO2: 93%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                  1,479 mL
                                                                    303 mL
   PO:
                                                                    795 mL
             TF:
   IVF:
                                                                    484 mL
                                                                    303 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                    900 mL
                                                                    400 mL
   Urine:
                                                                    900 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    579 mL
                                                                    -97 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 93%
   ABG: ///30/
   Physical Examination
   General Appearance: No acute distress
   Cardiovascular: (S1: Normal), (S2: Normal), no m/r/g, distant HS
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: No(t) Clear : , Diminished:
   throughout)
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed, diffuse maculopap rash more confluent today
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   10.6 g/dL
   293 K/uL
   110 mg/dL
   1.0 mg/dL
   30 mEq/L
   3.3 mEq/L
   14 mg/dL
   106 mEq/L
   142 mEq/L
   32.0 %
   9.0 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   Plt
   [**Telephone/Fax (2) 3249**]
   293
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   Other labs: PT / PTT / INR:12.7/45.1/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.4 mg/dL,
   Mg++:2.0 mg/dL, PO4:3.1 mg/dL
   Assessment and Plan
   HYPOXEMIA -- Attributed to new pneumonia on background of RSV
   infection. r/o for PE on [**12-14**] CT.
   -given clinical improvement favor bacterial nosocomial pna most likely;
   complete 8d course
   -encourage ambulation
   -defer bronch for now
   RSV infection -- s/p antibody treatment.
   RASH --  appears drug-related, and currently receiving several
   potential offenders, including contrast dye and cefepime
   CML s/p SCT c/b GVHD
 continue current level of care. Will d/w BMT
   service re: IvIg therapy and poss modification of steroid regimen
   GI GVHD -- continue oral swish and spit.
   NUTRITIONAL SUPPORT
 encourage PO with supplements.
   DEPRESSED MOOD -- consider pharmacological  intervention.
   ICU Care
   Nutrition:
   Glycemic Control:  Blood sugar well controlled
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :
   Total time spent: 45 minutes
   Patient is critically ill
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: PNA, RSV Bronchiolitis, Hypoxia
   I saw and examined the patient, and was physically present with the ICU
   Fellow for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   IV IG last PM, started on Flagyl. Rash is spreading despite stopping
   Cefopime, continuing on 6 liters. WBC down significantly. Afebrile last
   24 hrs
   History obtained from Patient
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-16**] 04:00 AM
   Aztreonam - [**2104-12-16**] 08:00 AM
   Acyclovir - [**2104-12-16**] 08:00 AM
   Metronidazole - [**2104-12-16**] 08:00 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2104-12-16**] 08:00 AM
   Omeprazole (Prilosec) - [**2104-12-16**] 08:00 AM
   Other medications:
   nebs q6, prednisone, hep SQ, dexamethasone swish and spit, MVI, Mag OX,
   Vit D, CaCO3, Vit C, Ursadiol, Ompeprazole, Cellcept, Folic A,
   Posiconizole, Cyclosporin, Acyclovir
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-16**] 10:36 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.6
C (97.8
   HR: 96 (84 - 103) bpm
   BP: 99/54(64) {77/42(52) - 118/78(86)} mmHg
   RR: 17 (15 - 23) insp/min
   SpO2: 93%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                  1,479 mL
                                                                    303 mL
   PO:
                                                                    795 mL
             TF:
   IVF:
                                                                    484 mL
                                                                    303 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                    900 mL
                                                                    400 mL
   Urine:
                                                                    900 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    579 mL
                                                                    -97 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 93%
   ABG: ///30/
   Physical Examination
   General Appearance: No acute distress
   Cardiovascular: (S1: Normal), (S2: Normal), no m/r/g, distant HS
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: No(t) Clear : , Diminished:
   throughout)
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed, diffuse maculopap rash more confluent today
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   10.6 g/dL
   293 K/uL
   110 mg/dL
   1.0 mg/dL
   30 mEq/L
   3.3 mEq/L
   14 mg/dL
   106 mEq/L
   142 mEq/L
   32.0 %
   9.0 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   Plt
   [**Telephone/Fax (2) 3249**]
   293
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   Other labs: PT / PTT / INR:12.7/45.1/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.4 mg/dL,
   Mg++:2.0 mg/dL, PO4:3.1 mg/dL
   Assessment and Plan
   HYPOXEMIA -- Attributed to new pneumonia on background of RSV
   infection. r/o for PE on [**12-14**] CT.
   -given clinical improvement favor bacterial nosocomial pna most likely;
   complete 8d course
   -encourage ambulation
   -defer bronch for now
   RSV infection -- s/p antibody treatment.
   RASH --  appears drug-related, and currently receiving several
   potential offenders, including contrast dye and cefepime
   CML s/p SCT c/b GVHD
 continue current level of care. Will d/w BMT
   service re: IvIg therapy and poss modification of steroid regimen
   GI GVHD -- continue oral swish and spit.
   NUTRITIONAL SUPPORT
 encourage PO with supplements.
   DEPRESSED MOOD -- consider pharmacological  intervention.
   ICU Care
   Nutrition:
   Glycemic Control:  Blood sugar well controlled
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :
   Total time spent: 45 minutes
   Patient is critically ill<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 78-inch tall, 76 kg male with a chief complaint of PNA (pneumonia) and RSV (respiratory syncytial virus) bronchiolitis, with ongoing hypoxia. The patient has been receiving IVIG (intravenous immunoglobulin) and antibiotics, including Flagyl, Cefopime, and Linezolid. The patient's rash is spreading despite stopping Cefopime, and their WBC count has decreased significantly. The patient is afebrile and receiving oxygen therapy via nasal cannula. They are also receiving other ICU medications, including Heparin, Omeprazole, and prednisone.

Potential Medical Complications:

1. Respiratory failure: The patient's ongoing hypoxia and PNA increase the risk of respiratory failure, which could require mechanical ventilation.
2. Sepsis: The patient's bacterial nosocomial PNA and spreading rash increase the risk of sepsis, which could lead to organ failure and death.
3. Gastrointestinal bleeding: The patient's history of GI GVHD (graft-versus-host disease) and use of anticoagulant medications increase the risk of gastrointestinal bleeding.
4. Dehydration: The patient's ongoing diarrhea and fluid loss through IV fluids and drainage tubes increase the risk of dehydration, which could lead to electrolyte imbalances and organ dysfunction.
5. Infection: The patient's RSV infection and ongoing antibiotic use increase the risk of infection, particularly with multidrug-resistant organisms.
6. Neurological complications: The patient's history of CML (chronic myeloid leukemia) and SCT (stem cell transplant) increase the risk of neurological complications, such as GVHD-related encephalopathy.
7. Cardiovascular complications: The patient's ongoing hypoxia and PNA increase the risk of cardiovascular complications, such as arrhythmias and cardiac failure.
8. Renal failure: The patient's history of CML and SCT increase the risk of renal failure, particularly if they develop sepsis or other complications.
9. Hepatic failure: The patient's history of CML and SCT increase the risk of hepatic failure, particularly if they develop sepsis or other complications.
10. Psychiatric complications: The patient's history of depression and ongoing ICU care increase the risk of psychiatric complications, such as anxiety and depression."
101091.0,273922,2104-12-16 10:36:00,Physician ,Physician Attending Progress Note,"Chief Complaint: PNA, RSV Bronchiolitis, Hypoxia
   I saw and examined the patient, and was physically present with the ICU
   Fellow for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   IV IG, bronch pending, starting on Flagyl. Rash is spreading despite
   stopping Cefopime, continuing on 6 liters
   History obtained from Patient
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-16**] 04:00 AM
   Aztreonam - [**2104-12-16**] 08:00 AM
   Acyclovir - [**2104-12-16**] 08:00 AM
   Metronidazole - [**2104-12-16**] 08:00 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2104-12-16**] 08:00 AM
   Omeprazole (Prilosec) - [**2104-12-16**] 08:00 AM
   Other medications:
   nebs q6, prednisone, hep SQ, dexamethasone swish and spit, MVI, Mag OX,
   Vit D, CaCO3, Vit C, Ursadiol, Ompeprazole, Cellcept, Folic A,
   Posiconizole, Cyclosporin, Acyclovir
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-16**] 10:36 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.6
C (97.8
   HR: 96 (84 - 103) bpm
   BP: 99/54(64) {77/42(52) - 118/78(86)} mmHg
   RR: 17 (15 - 23) insp/min
   SpO2: 93%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                  1,479 mL
                                                                    303 mL
   PO:
                                                                    795 mL
             TF:
   IVF:
                                                                    484 mL
                                                                    303 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                    900 mL
                                                                    400 mL
   Urine:
                                                                    900 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    579 mL
                                                                    -97 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 93%
   ABG: ///30/
   Physical Examination
   General Appearance: No acute distress
   Cardiovascular: (S1: Normal), (S2: Normal), no m/r/g, distant HS
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: No(t) Clear : , Diminished:
   throughout)
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed, diffuse maculopap rash more confluent today
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   10.6 g/dL
   293 K/uL
   110 mg/dL
   1.0 mg/dL
   30 mEq/L
   3.3 mEq/L
   14 mg/dL
   106 mEq/L
   142 mEq/L
   32.0 %
   9.0 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   Plt
   [**Telephone/Fax (3) 3249**]
   293
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   Other labs: PT / PTT / INR:12.7/45.1/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.4 mg/dL,
   Mg++:2.0 mg/dL, PO4:3.1 mg/dL
   Assessment and Plan
   HYPOXEMIA -- Attributed to new pneumonia on background of RSV
   infection. r/o for PE on [**12-14**] CT.
   -given clinical improvment favor bacterial nosocomial pna most likely;
   complete 8d course
   -encourage ambulation
   -defer bronch for now
   RSV infection -- s/p antibody treatment.
   RASH --  appears drug-related, and currently receiving several
   potential offenders, including contrast dye and cefepime
   CML s/p SCT c/b GVHD
 continue current level of care. Will d/w BMT
   service re: IvIg therapy and poss modification of steroid regimem
   GI GVHD -- continue oral swish and spit.
   NUTRITIONAL SUPPORT
 encourage PO with supplements. Keep npo for poss
   bronch this pm
   DEPRESSED MOOD -- consider pharmacological  intervention.
   ICU Care
   Nutrition:
   Glycemic Control:  Blood sugar well controlled
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :
   Total time spent: 45 minutes
   Patient is critically ill
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: PNA, RSV Bronchiolitis, Hypoxia
   I saw and examined the patient, and was physically present with the ICU
   Fellow for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   IV IG, bronch pending, starting on Flagyl. Rash is spreading despite
   stopping Cefopime, continuing on 6 liters
   History obtained from Patient
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-16**] 04:00 AM
   Aztreonam - [**2104-12-16**] 08:00 AM
   Acyclovir - [**2104-12-16**] 08:00 AM
   Metronidazole - [**2104-12-16**] 08:00 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2104-12-16**] 08:00 AM
   Omeprazole (Prilosec) - [**2104-12-16**] 08:00 AM
   Other medications:
   nebs q6, prednisone, hep SQ, dexamethasone swish and spit, MVI, Mag OX,
   Vit D, CaCO3, Vit C, Ursadiol, Ompeprazole, Cellcept, Folic A,
   Posiconizole, Cyclosporin, Acyclovir
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-16**] 10:36 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.6
C (97.8
   HR: 96 (84 - 103) bpm
   BP: 99/54(64) {77/42(52) - 118/78(86)} mmHg
   RR: 17 (15 - 23) insp/min
   SpO2: 93%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                  1,479 mL
                                                                    303 mL
   PO:
                                                                    795 mL
             TF:
   IVF:
                                                                    484 mL
                                                                    303 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                    900 mL
                                                                    400 mL
   Urine:
                                                                    900 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    579 mL
                                                                    -97 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 93%
   ABG: ///30/
   Physical Examination
   General Appearance: No acute distress
   Cardiovascular: (S1: Normal), (S2: Normal), no m/r/g, distant HS
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: No(t) Clear : , Diminished:
   throughout)
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed, diffuse maculopap rash more confluent today
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   10.6 g/dL
   293 K/uL
   110 mg/dL
   1.0 mg/dL
   30 mEq/L
   3.3 mEq/L
   14 mg/dL
   106 mEq/L
   142 mEq/L
   32.0 %
   9.0 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   Plt
   [**Telephone/Fax (3) 3249**]
   293
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   Other labs: PT / PTT / INR:12.7/45.1/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.4 mg/dL,
   Mg++:2.0 mg/dL, PO4:3.1 mg/dL
   Assessment and Plan
   HYPOXEMIA -- Attributed to new pneumonia on background of RSV
   infection. r/o for PE on [**12-14**] CT.
   -given clinical improvment favor bacterial nosocomial pna most likely;
   complete 8d course
   -encourage ambulation
   -defer bronch for now
   RSV infection -- s/p antibody treatment.
   RASH --  appears drug-related, and currently receiving several
   potential offenders, including contrast dye and cefepime
   CML s/p SCT c/b GVHD
 continue current level of care. Will d/w BMT
   service re: IvIg therapy and poss modification of steroid regimem
   GI GVHD -- continue oral swish and spit.
   NUTRITIONAL SUPPORT
 encourage PO with supplements. Keep npo for poss
   bronch this pm
   DEPRESSED MOOD -- consider pharmacological  intervention.
   ICU Care
   Nutrition:
   Glycemic Control:  Blood sugar well controlled
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :
   Total time spent: 45 minutes
   Patient is critically ill<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a critically ill child with a complex medical history, including respiratory syncytial virus (RSV) bronchiolitis, hypoxia, and a history of chemotherapy and stem cell transplantation (SCT) for chronic myeloid leukemia (CML).

The patient's current condition is characterized by:

1. Hypoxemia: The patient's oxygen saturation is 93% on nasal cannula, and an arterial blood gas (ABG) analysis shows a pH of 7.30, which indicates a mild respiratory acidosis.
2. Pneumonia: The patient has developed a new pneumonia, which is attributed to bacterial nosocomial pneumonia, likely caused by a drug-resistant organism.
3. Rash: The patient has a diffuse maculopapular rash, which is suspected to be drug-related, possibly caused by cefepime or contrast dye.
4. Gastrointestinal (GI) GVHD: The patient has GI GVHD, which is being managed with oral swish and spit.
5. Nutritional support: The patient is receiving nutritional support, including parenteral nutrition and oral supplements.
6. Depressed mood: The patient is experiencing a depressed mood, and pharmacological intervention is being considered.

Potential medical complications that can arise from these conditions include:

1. Respiratory failure: The patient's hypoxemia and pneumonia increase the risk of respiratory failure, which could require mechanical ventilation.
2. Sepsis: The patient's pneumonia and rash increase the risk of sepsis, which could lead to multi-organ dysfunction.
3. GI bleeding: The patient's GI GVHD and nutritional support increase the risk of GI bleeding, which could lead to hemorrhagic shock.
4. Infection: The patient's immunosuppressed state and presence of central lines increase the risk of central line-associated bloodstream infections (CLABSIs) and other infections.
5. Cardiovascular complications: The patient's hypoxemia and pneumonia increase the risk of cardiovascular complications, such as arrhythmias and cardiac failure.
6. Neurological complications: The patient's depressed mood and potential for sepsis increase the risk of neurological complications, such as seizures and encephalopathy.

To manage these potential complications, the patient requires close monitoring and aggressive treatment, including:

1. Oxygen therapy: The patient requires oxygen therapy to maintain adequate oxygen saturation.
2. Antibiotics: The patient requires antibiotics to treat the pneumonia, and consideration should be given to broad-spectrum antibiotics to cover potential drug-resistant organisms.
3. Pain management: The patient requires pain management to alleviate discomfort and distress.
4. Nutritional support: The patient requires continued nutritional support to maintain adequate caloric intake and prevent malnutrition.
5. Psychiatric support: The patient requires psychiatric support to manage depression and anxiety.
6. Regular monitoring: The patient requires regular monitoring of vital signs, laboratory results, and radiological imaging to detect potential complications early and intervene promptly."
101091.0,273922,2104-12-17 07:35:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   - O2 weaned down to 3L
   - no bronch done as clinically improving, likely has HAP and is
   responding to treatment
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-16**] 04:00 AM
   Aztreonam - [**2104-12-17**] 12:08 AM
   Acyclovir - [**2104-12-17**] 12:08 AM
   Metronidazole - [**2104-12-17**] 12:08 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2104-12-16**] 08:00 AM
   Heparin Sodium (Prophylaxis) - [**2104-12-17**] 12:08 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-17**] 07:34 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 96 (85 - 104) bpm
   BP: 114/71(78) {87/53(61) - 121/79(97)} mmHg
   RR: 16 (15 - 25) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    900 mL
                                                                    176 mL
   PO:
                                                                    360 mL
             TF:
   IVF:
                                                                    540 mL
                                                                    176 mL
   Blood products:
   Total out:
                                                                    575 mL
                                                                    150 mL
   Urine:
                                                                    575 mL
                                                                    150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    325 mL
                                                                     26 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 97%
   ABG: ///25/
   Physical Examination
   General Appearance: Middle-aged male lying in bed in NAD
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: RRR, no MRG
   Respiratory / Chest: Diminshed BS noted diffusely over lung fields,
   Crackles at right base
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: no edema
   Skin:  Warm, Rash improving: diffuse maculopapular over torso, back and
   neck, extending to lower legs and arms; all areas except face.  Rash is
   blanching.
   Neurologic: Attentive, alert and oriented x3
   Labs / Radiology
   303 K/uL
   10.7 g/dL
   89 mg/dL
   1.0 mg/dL
   25 mEq/L
   3.5 mEq/L
   12 mg/dL
   107 mEq/L
   141 mEq/L
   30.8 %
   7.8 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
                             [**2104-12-17**]  05:06 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   7.8
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   30.8
   Plt
   [**Telephone/Fax (2) 3249**]
   293
   303
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   89
   Other labs: PT / PTT / INR:12.9/47.8/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.3 mg/dL,
   Mg++:1.9 mg/dL, PO4:2.7 mg/dL
   Assessment and Plan
   55 yo M with h/o CML s/p MRD allo-SCT c/b GVHD of skin/gut on
   immunosuppression presenting with RSV bronchiolitis c/b hospital
   acquired pneumonia, transferred to the ICU with acute hypoxia now
   improved.
   # Hypoxia: Improved since admission to the ICU, now on 3L NC. Pt has
   been afebrile and his leukocytosis appears to be improving on his
   current antibiotic regimen. Will defer from bronchoscopy given his
   improvement in clinical status on his current antibiotics.
    - continue Linezolid (day #1 = [**2103-12-14**]), Aztreonam (day #1 = [**2103-12-14**]),
   cipro (day #1 [**12-14**]), and flagyl (day #1 [**12-16**]) ; had received 7 days of
   Vanc/Cefepime prior to this.   Will need an 8 day course from [**12-14**].
   - Continue ATC nebulizer treatment and prn albuterol
   - Continue to wean oxygen as needed
   - continue antifungals and acyclovir prophylaxis; was on pentamadine
   prior to admission for PCP prophylaxis
   [**Name Initial (PRE) **] [**Name9 (PRE) 229**] cultures with spikes, ECHO if cultures positive
   # Tachycardia: Patient has been in sinus tach on tele in the 90
s to
   100
s.  Is on 150 mg Toprol daily as an outpatient which has been held
   here.  Does not appear to be in pain, oxygenation is improving (no
   evidence of PE), and he appears to be euvolemic.
   - Start metoprolol 50 mg po bid.
   - Continue to monitor.
   # CML s/p transplant and GVHD: Pt received IVIG recently per heme/onc
   recommendations.  No additional recs noted this morning with continue
   current immunosuppression regimen.
   - Dexamethasone s/s for oral GVHD.
   - Continue current prophylactic agents with posaconazole and acyclovir.
   Received inhaled pentamidine as outpatient.
   - Continue ursodiol.
   # Rash: His rash is improving.  Was thought to be drug induced, may be
   related to Cefepime as he does have an allergy history to PCN V however
   he has received Cefepime in the past without any reactions.  Possible
   GVHD as well.
   - Will continue to monitor
   - Symptomatic treatment if necessary including benadryl, H2 blocker,
   increase steroids
   # Cardiomyopathy. Unlikely that his hypoxia is related to ACS as it
   improved with nebulizers.  No PND/orthopnea or other signs of
   decompensated heart failure.
   - Restart metoprolol as above.
   # Communication: [**First Name8 (NamePattern2) 3094**] [**Last Name (NamePattern1) 3231**] (daughter) [**Telephone/Fax (1) 3232**]
   ICU Care
   Nutrition: regular diet
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT: SQH
   Stress ulcer: PPI
   VAP:  N/A
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: Call out to the floor
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   - O2 weaned down to 3L
   - no bronch done as clinically improving, likely has HAP and is
   responding to treatment
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-16**] 04:00 AM
   Aztreonam - [**2104-12-17**] 12:08 AM
   Acyclovir - [**2104-12-17**] 12:08 AM
   Metronidazole - [**2104-12-17**] 12:08 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2104-12-16**] 08:00 AM
   Heparin Sodium (Prophylaxis) - [**2104-12-17**] 12:08 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-17**] 07:34 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 96 (85 - 104) bpm
   BP: 114/71(78) {87/53(61) - 121/79(97)} mmHg
   RR: 16 (15 - 25) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    900 mL
                                                                    176 mL
   PO:
                                                                    360 mL
             TF:
   IVF:
                                                                    540 mL
                                                                    176 mL
   Blood products:
   Total out:
                                                                    575 mL
                                                                    150 mL
   Urine:
                                                                    575 mL
                                                                    150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    325 mL
                                                                     26 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 97%
   ABG: ///25/
   Physical Examination
   General Appearance: Middle-aged male lying in bed in NAD
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: RRR, no MRG
   Respiratory / Chest: Diminshed BS noted diffusely over lung fields,
   Crackles at right base
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: no edema
   Skin:  Warm, Rash improving: diffuse maculopapular over torso, back and
   neck, extending to lower legs and arms; all areas except face.  Rash is
   blanching.
   Neurologic: Attentive, alert and oriented x3
   Labs / Radiology
   303 K/uL
   10.7 g/dL
   89 mg/dL
   1.0 mg/dL
   25 mEq/L
   3.5 mEq/L
   12 mg/dL
   107 mEq/L
   141 mEq/L
   30.8 %
   7.8 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
                             [**2104-12-17**]  05:06 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   7.8
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   30.8
   Plt
   [**Telephone/Fax (2) 3249**]
   293
   303
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   89
   Other labs: PT / PTT / INR:12.9/47.8/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.3 mg/dL,
   Mg++:1.9 mg/dL, PO4:2.7 mg/dL
   Assessment and Plan
   55 yo M with h/o CML s/p MRD allo-SCT c/b GVHD of skin/gut on
   immunosuppression presenting with RSV bronchiolitis c/b hospital
   acquired pneumonia, transferred to the ICU with acute hypoxia now
   improved.
   # Hypoxia: Improved since admission to the ICU, now on 3L NC. Pt has
   been afebrile and his leukocytosis appears to be improving on his
   current antibiotic regimen. Will defer from bronchoscopy given his
   improvement in clinical status on his current antibiotics.
    - continue Linezolid (day #1 = [**2103-12-14**]), Aztreonam (day #1 = [**2103-12-14**]),
   cipro (day #1 [**12-14**]), and flagyl (day #1 [**12-16**]) ; had received 7 days of
   Vanc/Cefepime prior to this.   Will need an 8 day course from [**12-14**].
   - Continue ATC nebulizer treatment and prn albuterol
   - Continue to wean oxygen as needed
   - continue antifungals and acyclovir prophylaxis; was on pentamadine
   prior to admission for PCP prophylaxis
   [**Name Initial (PRE) **] [**Name9 (PRE) 229**] cultures with spikes, ECHO if cultures positive
   # Tachycardia: Patient has been in sinus tach on tele in the 90
s to
   100
s.  Is on 150 mg Toprol daily as an outpatient which has been held
   here.  Does not appear to be in pain, oxygenation is improving (no
   evidence of PE), and he appears to be euvolemic.
   - Start metoprolol 50 mg po bid.
   - Continue to monitor.
   # CML s/p transplant and GVHD: Pt received IVIG recently per heme/onc
   recommendations.  No additional recs noted this morning with continue
   current immunosuppression regimen.
   - Dexamethasone s/s for oral GVHD.
   - Continue current prophylactic agents with posaconazole and acyclovir.
   Received inhaled pentamidine as outpatient.
   - Continue ursodiol.
   # Rash: His rash is improving.  Was thought to be drug induced, may be
   related to Cefepime as he does have an allergy history to PCN V however
   he has received Cefepime in the past without any reactions.  Possible
   GVHD as well.
   - Will continue to monitor
   - Symptomatic treatment if necessary including benadryl, H2 blocker,
   increase steroids
   # Cardiomyopathy. Unlikely that his hypoxia is related to ACS as it
   improved with nebulizers.  No PND/orthopnea or other signs of
   decompensated heart failure.
   - Restart metoprolol as above.
   # Communication: [**First Name8 (NamePattern2) 3094**] [**Last Name (NamePattern1) 3231**] (daughter) [**Telephone/Fax (1) 3232**]
   ICU Care
   Nutrition: regular diet
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT: SQH
   Stress ulcer: PPI
   VAP:  N/A
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: Call out to the floor<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 55-year-old male with a history of chronic myeloid leukemia (CML) who underwent allogenic stem cell transplant (allo-SCT) and developed graft-versus-host disease (GVHD) of the skin and gut. He was admitted to the hospital with respiratory syncytial virus (RSV) bronchiolitis and hospital-acquired pneumonia (HAP), and was transferred to the ICU due to acute hypoxia. 

The patient's condition has improved since admission to the ICU, with his hypoxia resolving and his leukocytosis appearing to improve on his current antibiotic regimen. He has been afebrile, and his rash is improving. 

Potential medical complications that may arise include:

1. Pneumonia: The patient has HAP, which may progress or develop complications such as respiratory failure, sepsis, or lung abscess.

2. Graft-versus-host disease (GVHD): The patient has a history of GVHD, which may worsen or develop new symptoms, such as gastrointestinal or skin manifestations.

3. Cytomegalovirus (CMV) infection: The patient is receiving antiviral prophylaxis, but may still be at risk for developing CMV infection.

4. Cardiomyopathy: The patient has a history of cardiomyopathy, which may worsen or develop new symptoms, such as chest pain, shortness of breath, or arrhythmias.

5. Hypoxia: The patient's oxygenation has improved, but may still be at risk for developing hypoxia if his respiratory status worsens.

6. Infection: The patient has a history of hospital-acquired pneumonia, and may still be at risk for developing new infections, such as ventilator-associated pneumonia (VAP) or catheter-associated urinary tract infection (CAUTI).

7. Bleeding: The patient has a history of bleeding complications, such as thrombocytopenia, which may worsen or develop new symptoms.

8. Neurological complications: The patient has a history of neurological symptoms, such as seizures or encephalopathy, which may worsen or develop new symptoms.

9. Endocrine complications: The patient has a history of endocrine disorders, such as hypothyroidism, which may worsen or develop new symptoms.

10. Nutritional complications: The patient may require nutritional support, such as total parenteral nutrition (TPN), which may lead to complications such as electrolyte imbalances or liver dysfunction.

It is essential to continue monitoring the patient's condition closely and adjusting his treatment plan as needed to prevent or manage these potential complications."
101091.0,273922,2104-12-17 07:35:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   - O2 weaned down to 4L
   - no broncho done as clinically improving, likely has HAP and is
   responding to treatment
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-16**] 04:00 AM
   Aztreonam - [**2104-12-17**] 12:08 AM
   Acyclovir - [**2104-12-17**] 12:08 AM
   Metronidazole - [**2104-12-17**] 12:08 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2104-12-16**] 08:00 AM
   Heparin Sodium (Prophylaxis) - [**2104-12-17**] 12:08 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-17**] 07:34 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 96 (85 - 104) bpm
   BP: 114/71(78) {87/53(61) - 121/79(97)} mmHg
   RR: 16 (15 - 25) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    900 mL
                                                                    176 mL
   PO:
                                                                    360 mL
             TF:
   IVF:
                                                                    540 mL
                                                                    176 mL
   Blood products:
   Total out:
                                                                    575 mL
                                                                    150 mL
   Urine:
                                                                    575 mL
                                                                    150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    325 mL
                                                                     26 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 97%
   ABG: ///25/
   Physical Examination
   General Appearance: Well nourished, No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (PMI Normal), (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: Diminshed BS noted diffusely over lung fields,
   Crackles at right base
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm, Rash: diffuse maculopapular over torso, back and neck,
   extending to lower legs and arms; all areas except face.  Rash is
   blanching.
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Oriented (to): person, place, time, Movement: Not assessed,
   Tone: Not assessed
   Labs / Radiology
   303 K/uL
   10.7 g/dL
   89 mg/dL
   1.0 mg/dL
   25 mEq/L
   3.5 mEq/L
   12 mg/dL
   107 mEq/L
   141 mEq/L
   30.8 %
   7.8 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
                             [**2104-12-17**]  05:06 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   7.8
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   30.8
   Plt
   [**Telephone/Fax (3) 3249**]
   293
   303
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   89
   Other labs: PT / PTT / INR:12.9/47.8/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.3 mg/dL,
   Mg++:1.9 mg/dL, PO4:2.7 mg/dL
   Assessment and Plan
   55 yo M with h/o CML s/p MRD allo-SCT c/b GVHD of skin/gut on
   immunosuppression presenting with RSV bronchiolitis c/b hospital
   acquired pneumonia, now with acute hypoxia.
   .
   # Hypoxia: Improved since admission to the ICU, now on 6L NC.  Pt did
   not clearly improve after last admission so current presentation may be
   manifestation of prior RSV illness.  Portable chest x-ray performed
   yesterday showed pneumonia to be resolving. Pt has been afebrile and
   his leukocytosis appears to be improving on his current antibiotic
   regimen. Will defer from bronchoscopy given his current improvement in
   clinical status on his current antibiotics. Will reimage tomorrow
   morning to assess PNA progress.
    - continue Linezolid (day #1 = [**2103-12-14**]) and Aztreonam (day #1 =
   [**2103-12-14**]); had received 7 days of Vanc/Cefepime prior to this.  Cipro
   started [**2103-12-14**] as well.
   - Repeat CXR Port in the AM
   - Continue ATC nebulizer treatment and prn albuterol
   - Continue to wean oxygen as needed
   - continue antifungals and acyclovir prophylaxis; was on pentamadine
   prior to admission for PCP prophylaxis
   [**Name Initial (PRE) **] [**Name9 (PRE) 229**] cultures with spikes, ECHO if cultures positive
   .
   # CML s/p transplant and GVHD: Pt received IVIG yesterday per heme/onc
   recommendations.  No additional recs noted this morning with continue
   current immunosuppression regimen.
   - Dexamethasone s/s for oral GVHD.
   - Continue current prophylactic agents with posaconazole and acyclovir.
   Received inhaled pentamidine as outpatient.
   - Continue ursodiol.
   .
   # Rash: Appears to be drug induced, may be related to Cefepime as he
   does have an allergy history to PCN V however he has received Cefepime
   in the past without any reactions.   Appears to be new today.  Patient
   does not recall having had it prior, and nursing from BMT floor did not
   report it to nursing.  Cause includes drug-induced from cefepime
   (patient is allergic to pen VK) though he has been on this multiple
   times in the past.  Also could be secondary to IV contrast though from
   CTA yesterday as nursing does not think rash was present prior, though
   he has had IV contrast in the past as well.  No other apparent new
   drugs.  Possible GVHD as well.
   - Will continue to monitor
   - Symptomatic treatment if necessary including benadryl, H2 blocker,
   increase steroids
   .
   # Cardiomyopathy: continue outpatient metoprolol XL. Unlikely that his
   hypoxia is related to ACS as it improved with nebulizers.  No
   PND/orthopnea or other signs of decompensated heart failure.
   .
   # FEN: cardiac diet, follow/replete electrolytes, continue standing
   magnesium repletion.
   .
   # Communication: [**First Name8 (NamePattern2) 3094**] [**Last Name (NamePattern1) 3231**] (daughter) [**Telephone/Fax (1) 3232**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   - O2 weaned down to 4L
   - no broncho done as clinically improving, likely has HAP and is
   responding to treatment
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-16**] 04:00 AM
   Aztreonam - [**2104-12-17**] 12:08 AM
   Acyclovir - [**2104-12-17**] 12:08 AM
   Metronidazole - [**2104-12-17**] 12:08 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2104-12-16**] 08:00 AM
   Heparin Sodium (Prophylaxis) - [**2104-12-17**] 12:08 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-17**] 07:34 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 96 (85 - 104) bpm
   BP: 114/71(78) {87/53(61) - 121/79(97)} mmHg
   RR: 16 (15 - 25) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    900 mL
                                                                    176 mL
   PO:
                                                                    360 mL
             TF:
   IVF:
                                                                    540 mL
                                                                    176 mL
   Blood products:
   Total out:
                                                                    575 mL
                                                                    150 mL
   Urine:
                                                                    575 mL
                                                                    150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    325 mL
                                                                     26 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 97%
   ABG: ///25/
   Physical Examination
   General Appearance: Well nourished, No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (PMI Normal), (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: Diminshed BS noted diffusely over lung fields,
   Crackles at right base
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm, Rash: diffuse maculopapular over torso, back and neck,
   extending to lower legs and arms; all areas except face.  Rash is
   blanching.
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Oriented (to): person, place, time, Movement: Not assessed,
   Tone: Not assessed
   Labs / Radiology
   303 K/uL
   10.7 g/dL
   89 mg/dL
   1.0 mg/dL
   25 mEq/L
   3.5 mEq/L
   12 mg/dL
   107 mEq/L
   141 mEq/L
   30.8 %
   7.8 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
                             [**2104-12-17**]  05:06 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   7.8
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   30.8
   Plt
   [**Telephone/Fax (3) 3249**]
   293
   303
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   89
   Other labs: PT / PTT / INR:12.9/47.8/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.3 mg/dL,
   Mg++:1.9 mg/dL, PO4:2.7 mg/dL
   Assessment and Plan
   55 yo M with h/o CML s/p MRD allo-SCT c/b GVHD of skin/gut on
   immunosuppression presenting with RSV bronchiolitis c/b hospital
   acquired pneumonia, now with acute hypoxia.
   .
   # Hypoxia: Improved since admission to the ICU, now on 6L NC.  Pt did
   not clearly improve after last admission so current presentation may be
   manifestation of prior RSV illness.  Portable chest x-ray performed
   yesterday showed pneumonia to be resolving. Pt has been afebrile and
   his leukocytosis appears to be improving on his current antibiotic
   regimen. Will defer from bronchoscopy given his current improvement in
   clinical status on his current antibiotics. Will reimage tomorrow
   morning to assess PNA progress.
    - continue Linezolid (day #1 = [**2103-12-14**]) and Aztreonam (day #1 =
   [**2103-12-14**]); had received 7 days of Vanc/Cefepime prior to this.  Cipro
   started [**2103-12-14**] as well.
   - Repeat CXR Port in the AM
   - Continue ATC nebulizer treatment and prn albuterol
   - Continue to wean oxygen as needed
   - continue antifungals and acyclovir prophylaxis; was on pentamadine
   prior to admission for PCP prophylaxis
   [**Name Initial (PRE) **] [**Name9 (PRE) 229**] cultures with spikes, ECHO if cultures positive
   .
   # CML s/p transplant and GVHD: Pt received IVIG yesterday per heme/onc
   recommendations.  No additional recs noted this morning with continue
   current immunosuppression regimen.
   - Dexamethasone s/s for oral GVHD.
   - Continue current prophylactic agents with posaconazole and acyclovir.
   Received inhaled pentamidine as outpatient.
   - Continue ursodiol.
   .
   # Rash: Appears to be drug induced, may be related to Cefepime as he
   does have an allergy history to PCN V however he has received Cefepime
   in the past without any reactions.   Appears to be new today.  Patient
   does not recall having had it prior, and nursing from BMT floor did not
   report it to nursing.  Cause includes drug-induced from cefepime
   (patient is allergic to pen VK) though he has been on this multiple
   times in the past.  Also could be secondary to IV contrast though from
   CTA yesterday as nursing does not think rash was present prior, though
   he has had IV contrast in the past as well.  No other apparent new
   drugs.  Possible GVHD as well.
   - Will continue to monitor
   - Symptomatic treatment if necessary including benadryl, H2 blocker,
   increase steroids
   .
   # Cardiomyopathy: continue outpatient metoprolol XL. Unlikely that his
   hypoxia is related to ACS as it improved with nebulizers.  No
   PND/orthopnea or other signs of decompensated heart failure.
   .
   # FEN: cardiac diet, follow/replete electrolytes, continue standing
   magnesium repletion.
   .
   # Communication: [**First Name8 (NamePattern2) 3094**] [**Last Name (NamePattern1) 3231**] (daughter) [**Telephone/Fax (1) 3232**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 55-year-old male with a history of chronic myeloid leukemia (CML) who underwent allogenic stem cell transplant (allo-SCT) and developed graft-versus-host disease (GVHD) of the skin and gut. He was admitted to the ICU with respiratory syncytial virus (RSV) bronchiolitis and hospital-acquired pneumonia, which has since improved with antibiotic treatment.

The patient's current condition is as follows:

* Vital signs: stable, with a temperature of 36.8°C (98.2°F), heart rate of 96 beats per minute, blood pressure of 114/71 mmHg, and respiratory rate of 16 breaths per minute.
* Respiratory support: oxygen therapy via nasal cannula, with a SpO2 of 97%.
* Cardiovascular: no acute distress, with a normal sinus rhythm and no signs of cardiomyopathy.
* Neurological: alert and oriented, with no signs of increased intracranial pressure or neurological deficits.
* Laboratory results: white blood cell count of 10.3 x 10^9/L, hemoglobin of 10.7 g/dL, and platelet count of 293 x 10^9/L.
* Medications: continuing linezolid, aztreonam, ciprofloxacin, and acyclovir, as well as immunosuppressive agents for GVHD.

Potential medical complications that may arise include:

1. Pneumonia: despite improvement, the patient's pneumonia may not fully resolve, leading to prolonged hospitalization and increased risk of complications.
2. GVHD: the patient's GVHD may worsen, leading to increased risk of organ failure and mortality.
3. Infections: the patient's immunosuppressed state may increase his risk of developing secondary infections, including fungal and viral infections.
4. Cardiomyopathy: the patient's cardiomyopathy may worsen, leading to decreased cardiac function and increased risk of mortality.
5. Hypoxia: the patient's hypoxia may worsen, leading to respiratory failure and increased risk of mortality.
6. Electrolyte imbalances: the patient's electrolyte imbalances may worsen, leading to cardiac arrhythmias and decreased cardiac function.
7. Wound complications: the patient's wounds may become infected or develop complications, leading to increased risk of morbidity and mortality.

Based on the patient's current condition and potential complications, it is recommended that he continue to receive close monitoring and treatment in the ICU, with regular reassessments of his condition and adjustment of his treatment plan as necessary."
101091.0,273922,2104-12-17 09:41:00,Physician ,Physician Attending Progress Note,"Chief Complaint:
   I saw and examined the patient, and was physically present with the ICU
   Fellow for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   O2 weaned to 3L from 6LNC yest. This AM no SOB, no complaints.
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-16**] 04:00 AM
   Aztreonam - [**2104-12-17**] 08:39 AM
   Acyclovir - [**2104-12-17**] 08:40 AM
   Metronidazole - [**2104-12-17**] 08:40 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2104-12-17**] 08:40 AM
   Omeprazole (Prilosec) - [**2104-12-17**] 08:42 AM
   Other medications:
   Atrovent, Albuterol, Prednisone, MVI, CaHCO3, ursodiol, Cellcept,
   folate, posaconazole, cyclosporine
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-17**] 09:41 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.6
C (97.9
   HR: 104 (85 - 104) bpm
   BP: 104/66(76) {87/53(61) - 121/79(97)} mmHg
   RR: 19 (15 - 25) insp/min
   SpO2: 95%
   Heart rhythm: ST (Sinus Tachycardia)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    900 mL
                                                                    294 mL
   PO:
                                                                    360 mL
             TF:
   IVF:
                                                                    540 mL
                                                                    294 mL
   Blood products:
   Total out:
                                                                    575 mL
                                                                    500 mL
   Urine:
                                                                    575 mL
                                                                    500 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    325 mL
                                                                   -206 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 95%
   ABG: ///25/
   Physical Examination
   General Appearance: No acute distress, Thin
   Eyes / Conjunctiva: PERRL
   Cardiovascular: (S1: Normal), (S2: Normal), no m/r/g
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: Crackles : b bases L > R)
   Skin:  Not assessed, Rash: resolving maculopap rash
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   10.7 g/dL
   303 K/uL
   89 mg/dL
   1.0 mg/dL
   25 mEq/L
   3.5 mEq/L
   12 mg/dL
   107 mEq/L
   141 mEq/L
   30.8 %
   7.8 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
                             [**2104-12-17**]  05:06 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   7.8
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   30.8
   Plt
   [**Telephone/Fax (2) 3249**]
   293
   303
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   89
   Other labs: PT / PTT / INR:12.9/47.8/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.3 mg/dL,
   Mg++:1.9 mg/dL, PO4:2.7 mg/dL
   Imaging: CXR- subtle patchy infiltrates
   Microbiology: CMV- pending
   galactomannan- pending
   Assessment and Plan
   NOSOCOMIAL PNEUMONIA-- background of RSV infection, clinically
   resolving. r/o for PE on [**12-14**] CT.
   -given clinical improvement favor bacterial nosocomial pna most likely;
   complete 8d course (through [**12-21**])
   -encourage ambulation
   RSV infection -- s/p antibody treatment.
   RASH --  appears drug-related, and currently receiving several
   potential offenders, including contrast dye and cefepime
   CML s/p SCT c/b GVHD
 continue current level of care. Will d/w BMT
   service re: IvIg therapy and poss modification of steroid regimen
   -on immunosuppressive regimen per BMT svce. ? need to follow
   cyclosporine levels?
   GI GVHD -- continue oral swish and spit.
   NUTRITIONAL SUPPORT
 encourage PO with supplements.
   DEPRESSED MOOD -- consider pharmacological  intervention.
   ICU Care
   Nutrition:
   Glycemic Control:  Blood sugar well controlled
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :Transfer to floor
   Total time spent: 30 minutes
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   I saw and examined the patient, and was physically present with the ICU
   Fellow for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   O2 weaned to 3L from 6LNC yest. This AM no SOB, no complaints.
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-16**] 04:00 AM
   Aztreonam - [**2104-12-17**] 08:39 AM
   Acyclovir - [**2104-12-17**] 08:40 AM
   Metronidazole - [**2104-12-17**] 08:40 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2104-12-17**] 08:40 AM
   Omeprazole (Prilosec) - [**2104-12-17**] 08:42 AM
   Other medications:
   Atrovent, Albuterol, Prednisone, MVI, CaHCO3, ursodiol, Cellcept,
   folate, posaconazole, cyclosporine
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-17**] 09:41 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.6
C (97.9
   HR: 104 (85 - 104) bpm
   BP: 104/66(76) {87/53(61) - 121/79(97)} mmHg
   RR: 19 (15 - 25) insp/min
   SpO2: 95%
   Heart rhythm: ST (Sinus Tachycardia)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    900 mL
                                                                    294 mL
   PO:
                                                                    360 mL
             TF:
   IVF:
                                                                    540 mL
                                                                    294 mL
   Blood products:
   Total out:
                                                                    575 mL
                                                                    500 mL
   Urine:
                                                                    575 mL
                                                                    500 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    325 mL
                                                                   -206 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 95%
   ABG: ///25/
   Physical Examination
   General Appearance: No acute distress, Thin
   Eyes / Conjunctiva: PERRL
   Cardiovascular: (S1: Normal), (S2: Normal), no m/r/g
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: Crackles : b bases L > R)
   Skin:  Not assessed, Rash: resolving maculopap rash
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   10.7 g/dL
   303 K/uL
   89 mg/dL
   1.0 mg/dL
   25 mEq/L
   3.5 mEq/L
   12 mg/dL
   107 mEq/L
   141 mEq/L
   30.8 %
   7.8 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
                             [**2104-12-17**]  05:06 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   7.8
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   30.8
   Plt
   [**Telephone/Fax (2) 3249**]
   293
   303
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   89
   Other labs: PT / PTT / INR:12.9/47.8/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.3 mg/dL,
   Mg++:1.9 mg/dL, PO4:2.7 mg/dL
   Imaging: CXR- subtle patchy infiltrates
   Microbiology: CMV- pending
   galactomannan- pending
   Assessment and Plan
   NOSOCOMIAL PNEUMONIA-- background of RSV infection, clinically
   resolving. r/o for PE on [**12-14**] CT.
   -given clinical improvement favor bacterial nosocomial pna most likely;
   complete 8d course (through [**12-21**])
   -encourage ambulation
   RSV infection -- s/p antibody treatment.
   RASH --  appears drug-related, and currently receiving several
   potential offenders, including contrast dye and cefepime
   CML s/p SCT c/b GVHD
 continue current level of care. Will d/w BMT
   service re: IvIg therapy and poss modification of steroid regimen
   -on immunosuppressive regimen per BMT svce. ? need to follow
   cyclosporine levels?
   GI GVHD -- continue oral swish and spit.
   NUTRITIONAL SUPPORT
 encourage PO with supplements.
   DEPRESSED MOOD -- consider pharmacological  intervention.
   ICU Care
   Nutrition:
   Glycemic Control:  Blood sugar well controlled
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :Transfer to floor
   Total time spent: 30 minutes<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 78-inch tall, 76 kg male with a history of CML, s/p SCT, and c/b GVHD. He was admitted to the ICU with a diagnosis of nosocomial pneumonia, RSV infection, and rash. The patient's condition has been improving clinically, with a decrease in oxygen requirements and a resolving rash. However, he still has a background of RSV infection and is at risk for developing PE.

The patient's vital signs are stable, with a temperature of 36.6°C, heart rate of 104 bpm, and blood pressure of 104/66 mmHg. His respiratory status is stable, with an SpO2 of 95% on nasal cannula oxygen. His laboratory results show a white blood cell count of 10.3 K/uL, hemoglobin of 10.7 g/dL, and platelet count of 293 K/uL.

The patient is receiving multiple medications, including antibiotics, antivirals, and immunosuppressive agents. He is also receiving nutritional support and has been encouraged to ambulate.

Potential Medical Complications:

1. Nosocomial pneumonia: The patient is at risk for developing a nosocomial pneumonia, which could be caused by bacteria such as MRSA or VRE.
2. Pulmonary embolism: The patient's history of RSV infection and his current respiratory status make him at risk for developing a pulmonary embolism.
3. Gastrointestinal graft-versus-host disease: The patient's history of GVHD and his current gastrointestinal symptoms make him at risk for developing gastrointestinal graft-versus-host disease.
4. Central nervous system graft-versus-host disease: The patient's history of GVHD and his current neurological symptoms make him at risk for developing central nervous system graft-versus-host disease.
5. Infection: The patient's immunocompromised state and his current respiratory status make him at risk for developing an infection.
6. Bleeding: The patient's platelet count is low, which makes him at risk for bleeding.
7. Nutritional deficiencies: The patient's gastrointestinal symptoms and his current nutritional status make him at risk for developing nutritional deficiencies.
8. Depression: The patient's history of depression and his current depressed mood make him at risk for developing depression."
101091.0,273922,2104-12-17 09:41:00,Physician ,Physician Attending Progress Note,"Chief Complaint:
   I saw and examined the patient, and was physically present with the ICU
   Fellow for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   O2 weaned to 3L from 6LNC yest. This AM no SOB, no complaints.
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-16**] 04:00 AM
   Aztreonam - [**2104-12-17**] 08:39 AM
   Acyclovir - [**2104-12-17**] 08:40 AM
   Metronidazole - [**2104-12-17**] 08:40 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2104-12-17**] 08:40 AM
   Omeprazole (Prilosec) - [**2104-12-17**] 08:42 AM
   Other medications:
   Atrovent, Albuterol, Prednisone, MVI, CaHCO3, ursodiol, Cellcept,
   folate, posaconazole, cyclosporine
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-17**] 09:41 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.6
C (97.9
   HR: 104 (85 - 104) bpm
   BP: 104/66(76) {87/53(61) - 121/79(97)} mmHg
   RR: 19 (15 - 25) insp/min
   SpO2: 95%
   Heart rhythm: ST (Sinus Tachycardia)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    900 mL
                                                                    294 mL
   PO:
                                                                    360 mL
             TF:
   IVF:
                                                                    540 mL
                                                                    294 mL
   Blood products:
   Total out:
                                                                    575 mL
                                                                    500 mL
   Urine:
                                                                    575 mL
                                                                    500 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    325 mL
                                                                   -206 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 95%
   ABG: ///25/
   Physical Examination
   General Appearance: No acute distress, Thin
   Eyes / Conjunctiva: PERRL
   Cardiovascular: (S1: Normal), (S2: Normal), no m/r/g
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: Crackles : b bases L > R)
   Skin:  Not assessed, Rash: resolving maculopap rash
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   10.7 g/dL
   303 K/uL
   89 mg/dL
   1.0 mg/dL
   25 mEq/L
   3.5 mEq/L
   12 mg/dL
   107 mEq/L
   141 mEq/L
   30.8 %
   7.8 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
                             [**2104-12-17**]  05:06 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   7.8
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   30.8
   Plt
   [**Telephone/Fax (2) 3249**]
   293
   303
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   89
   Other labs: PT / PTT / INR:12.9/47.8/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.3 mg/dL,
   Mg++:1.9 mg/dL, PO4:2.7 mg/dL
   Imaging: CXR- subtle patchy infiltrates
   Microbiology: CMV- pending
   galactomannan- pending
   Assessment and Plan
   NOSOCOMIAL PNEUMONIA-- background of RSV infection, clinically
   resolving. r/o for PE on [**12-14**] CT.
   -given clinical improvement favor bacterial nosocomial pna most likely;
   complete 8d course (through [**12-21**])
   -encourage ambulation
   RSV infection -- s/p antibody treatment.
   RASH --  appears drug-related, and currently receiving several
   potential offenders, including contrast dye and cefepime
   CML s/p SCT c/b GVHD
 continue current level of care. Will d/w BMT
   service re: IvIg therapy and poss modification of steroid regimen
   -on immunosuppressive regimen per BMT svce. ? need to follow
   cyclosporine levels?
   GI GVHD -- continue oral swish and spit.
   NUTRITIONAL SUPPORT
 encourage PO with supplements.
   DEPRESSED MOOD -- consider pharmacological  intervention.
   ICU Care
   Nutrition:
   Glycemic Control:  Blood sugar well controlled
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :Transfer to floor
   Total time spent: 30 minutes
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   I saw and examined the patient, and was physically present with the ICU
   Fellow for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   O2 weaned to 3L from 6LNC yest. This AM no SOB, no complaints.
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-16**] 04:00 AM
   Aztreonam - [**2104-12-17**] 08:39 AM
   Acyclovir - [**2104-12-17**] 08:40 AM
   Metronidazole - [**2104-12-17**] 08:40 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2104-12-17**] 08:40 AM
   Omeprazole (Prilosec) - [**2104-12-17**] 08:42 AM
   Other medications:
   Atrovent, Albuterol, Prednisone, MVI, CaHCO3, ursodiol, Cellcept,
   folate, posaconazole, cyclosporine
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-17**] 09:41 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.6
C (97.9
   HR: 104 (85 - 104) bpm
   BP: 104/66(76) {87/53(61) - 121/79(97)} mmHg
   RR: 19 (15 - 25) insp/min
   SpO2: 95%
   Heart rhythm: ST (Sinus Tachycardia)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    900 mL
                                                                    294 mL
   PO:
                                                                    360 mL
             TF:
   IVF:
                                                                    540 mL
                                                                    294 mL
   Blood products:
   Total out:
                                                                    575 mL
                                                                    500 mL
   Urine:
                                                                    575 mL
                                                                    500 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    325 mL
                                                                   -206 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 95%
   ABG: ///25/
   Physical Examination
   General Appearance: No acute distress, Thin
   Eyes / Conjunctiva: PERRL
   Cardiovascular: (S1: Normal), (S2: Normal), no m/r/g
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: Crackles : b bases L > R)
   Skin:  Not assessed, Rash: resolving maculopap rash
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   10.7 g/dL
   303 K/uL
   89 mg/dL
   1.0 mg/dL
   25 mEq/L
   3.5 mEq/L
   12 mg/dL
   107 mEq/L
   141 mEq/L
   30.8 %
   7.8 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
                             [**2104-12-17**]  05:06 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   7.8
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   30.8
   Plt
   [**Telephone/Fax (2) 3249**]
   293
   303
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   89
   Other labs: PT / PTT / INR:12.9/47.8/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.3 mg/dL,
   Mg++:1.9 mg/dL, PO4:2.7 mg/dL
   Imaging: CXR- subtle patchy infiltrates
   Microbiology: CMV- pending
   galactomannan- pending
   Assessment and Plan
   NOSOCOMIAL PNEUMONIA-- background of RSV infection, clinically
   resolving. r/o for PE on [**12-14**] CT.
   -given clinical improvement favor bacterial nosocomial pna most likely;
   complete 8d course (through [**12-21**])
   -encourage ambulation
   RSV infection -- s/p antibody treatment.
   RASH --  appears drug-related, and currently receiving several
   potential offenders, including contrast dye and cefepime
   CML s/p SCT c/b GVHD
 continue current level of care. Will d/w BMT
   service re: IvIg therapy and poss modification of steroid regimen
   -on immunosuppressive regimen per BMT svce. ? need to follow
   cyclosporine levels?
   GI GVHD -- continue oral swish and spit.
   NUTRITIONAL SUPPORT
 encourage PO with supplements.
   DEPRESSED MOOD -- consider pharmacological  intervention.
   ICU Care
   Nutrition:
   Glycemic Control:  Blood sugar well controlled
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :Transfer to floor
   Total time spent: 30 minutes<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 78-inch tall, 76 kg individual who has been admitted to the ICU due to a background of RSV infection, clinically resolving, and nosocomial pneumonia. They have a history of CML, s/p SCT, c/b GVHD, and are currently on immunosuppressive regimen. The patient has a rash that appears to be drug-related, and is receiving several potential offenders, including contrast dye and cefepime. They have also been treated with antibody therapy for RSV infection.

The patient's vital signs are stable, with a temperature of 36.8°C, heart rate of 104 bpm, and blood pressure of 104/66 mmHg. Their respiratory rate is 19 breaths per minute, and oxygen saturation is 95%. They have a sinus tachycardia rhythm and a normal S1 and S2 heart sounds.

The patient's laboratory results show a white blood cell count of 10.3, hemoglobin of 10.7 g/dL, and platelet count of 293. Their creatinine is 1.3 mg/dL, and their glucose is 90 mg/dL. They have a subtle patchy infiltrate on their chest X-ray, and are pending for CMV and galactomannan tests.

Assessment and Plan:

The patient is diagnosed with nosocomial pneumonia, which is clinically resolving. They are to continue on their current level of care and complete an 8-day course of antibiotics. They are also to be encouraged to ambulate.

The patient's rash is suspected to be drug-related and is being treated with several potential offenders. They are to continue on their immunosuppressive regimen and have their cyclosporine levels followed.

The patient is also being treated for GI GVHD, and is to continue with oral swish and spit. They are to be encouraged to take PO with supplements, and have their nutritional support monitored.

Potential Medical Complications:

1. Nosocomial pneumonia: The patient's pneumonia is clinically resolving, but they are still at risk for complications such as respiratory failure, sepsis, and multi-organ failure.
2. GVHD: The patient has a history of CML and has undergone SCT, which puts them at risk for GVHD. They are currently on immunosuppressive therapy, but they may still develop GVHD, which can cause a range of symptoms including skin rash, gastrointestinal symptoms, and liver dysfunction.
3. Rash: The patient's rash is suspected to be drug-related, but it may still cause discomfort and skin breakdown. They may also develop skin infections or other complications.
4. Depression: The patient has a history of depression and is currently being treated with antidepressant medication. They may still develop depression or other mood disorders.
5. Nutritional deficiencies: The patient is at risk for nutritional deficiencies due to their history of CML and GVHD. They may need to be monitored for deficiencies in vitamins and minerals.
6. Infection: The patient is at risk for infection due to their immunosuppressive therapy and history of CML. They may develop infections such as pneumonia, sepsis, or urinary tract infections."
